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Chapter 1 
INTRODUCTION 
 
There’s a rainbow shining in a bead of spittle 
Falling diamonds in rattling rain 
Light flexed on moving muscle 
I stand here dazzled with my heart in flames 
At this world of wonders 
 
“World of Wonders” 
--Bruce Cockburn 
 
Our world is full of wondrous things. From the shimmer of a child’s laughter to 
the intricate painting of a ladybug’s shoulders, our home is colored with an infinite, 
incandescent kind of splendor. Thousands of years of poetry, artistry, and science have 
taught us that the natural world is nothing short of magnanimous. What better gift could 
we have been given than that of God’s exquisite creation?  
 
I’ve never been the kind of person who finds much spiritual solace in the church. I 
can’t deny that gothic-style cathedrals with expansive acoustics and well-ordered pews 
do not astound me; it’s the people, rather, that make me hesitant to find sanctuary in these 
places. History tells us that organized religion can be a fickle thing, an institution 
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wrought with human folly. Where do the rest of us fit in, the folks who struggle 
desperately to hear God over the mindless din?   
 When I first came to Regis, I had very little faith. I had spent my high school 
years fighting tooth and nail to belong, and, consequently, had little time to spend 
thinking about spirituality. I grew up among religious hypocrites, people who depicted 
God as a malicious, judgmental, and all-around unlikeable guy. While I found some 
comfort in my music, a passion that distracted me from the harsher parts of high school, I 
still had no clue how to relate to a God so distant. I was spiritually stuck—where was this 
God that I had heard about, a God who was supposedly a trusted advisor, confidant, and 
friend?  
 My first year at Regis was spent almost entirely ignoring God. I had been given 
the incredible gift of a scholarship in biology, a kind of “golden handcuffs” that pushed 
me in the direction of the natural sciences. I had always been good at science; so, 
naturally, I figured I should become a doctor. I kept on telling myself that this was what I 
wanted, that this would make God happy with me. Like many other honors students, I 
loaded my schedule with mindless activities and fruitless distractions. It was much too 
difficult to face the reality of my confusion.  
I will never forget the day that I found my vocation. At the time, I had been taking 
genetics and had (quite literally) fallen in love with it. Years of biology lectures had 
finally culminated in some truly astounding “aha” moments—I felt as if my soul had 
finally been nourished. One bleak February afternoon, I was working in the biology prep 
room and had been tasked with the infamous job of cleaning up fly larvae for the labs. As 
  
 
3 
I meticulously washed each vial with a small scrubber and felt the hot water run over my 
hands, I hummed a tune that I had been learning in my voice lesson. I looked outside the 
prep room window to see snow falling peacefully on campus. In that moment, I felt a sort 
of simple, passionate peace while watching the water and soap circle the drain. I was 
finally allowing myself to feel the avalanche of emotion that I had bottled up for years. 
God was right there, nudging me to consider a future dedicated to the relentless pursuit of 
His creation, a future full of fly larvae, failed experiments, and ultimate wonder. In that 
moment, I felt a clarity of thought and emotion that demolished all of my old dreams; I 
knew I needed to become a scientist.  
Much like listening to a good piece of music or seeing the face of a loved one, I 
felt myself opening up to new experiences over the next few years. As I devoured 
knowledge of the perfect structure of the helix, the ecosystem of a living cell, and the 
breathtaking homology of the animal kingdom, I cultivated a more beautiful image of 
God. I have come to realize one most precious thing—that the God of my childhood does 
not exist. He who revealed Himself to me that day in the prep room is the same God who 
made the cosmos, a universe both beautifully simple and vastly complex; namely, a God 
with one hell of a personality. The laboratory has become my church, the benchtop my 
pew, and the microscope a sacrament of my devotion to the divine. Forget the judgmental 
God that years of bible school shoved down my throat—give me nature’s God, a God that 
made people like me who crave to know the infinite.  
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 I found the inspiration to write about homology from the most unexciting of 
sources—my junior seminar on biology research literature. Tasked with the opportunity 
to write about any current topic in evolution, I found myself fascinated with the 
molecular similarities between members of the animal kingdom. I remember devouring 
Sean Carroll’s publications on deep homology. How could anything be more fascinating 
than the concept of an ancient genetic toolkit? I couldn’t believe that I had never heard of 
Urbilateria, the Hox clock, or convergent evolution. The possibility of studying life from 
both the molecular and organismic perspectives quickly drew me into an obsession even 
more intense than that of genetics—developmental biology.  
In my need to know more, I spent the entirety of my winter break that year 
applying to almost every developmental laboratory across the country that offered a 
summer undergraduate internship position. The first invitation that I received ended up 
being the perfect fit, and I was all set to work at Cincinnati Children’s Hospital in a 
zebrafish lab studying vasculogenesis. Armed with the knowledge that I had learned from 
my developmental biology lecture, I hopped onto a plane and embarked on my first solo 
adventure in the Midwest. At first glance, my project seemed to have nothing to do with 
evolution; by the end of the summer, however, I had realized that the proteins I was 
working with were in fact homologs in numerous other model organism systems. It all 
seemed to fall into place—I would be able to write about my fantastic summer research, 
all within the scope of my beloved evo-devo.  
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 Contrary to what the seniors told me would happen my freshman year of honors, I 
have thoroughly enjoyed writing this thesis. Both intricately academic and profoundly 
personal, this last year of writing has helped me to develop a confidence in my chosen 
vocation that I couldn’t have thought possible. I walked into this journey with a love for 
homology and now have a deeper understanding of its role in God’s artistry. Many of the 
questions that I posed at the beginning of this process remain unanswered; it is through 
these uncertainties, however, that I have had the most fun.  
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Chapter 2 
WHAT IS HOMOLOGY? 
 
2.1: Introduction 
We are in the midst of a genomic revolution. Beginning with the completion of 
the human genome project at the turn of the century, research across the life sciences has 
quickly become reliant on computational methodologies and bulk data analysis. This 
phenomenon of dependence has been seen across a wide array of subfields, with 
genomics informing our understanding of both conservation biology and biomedical 
inquiry. Genomics is to our generation what nuclear physics was to our grandparents—
flashy, alluring, and full of possibilities.  
In the presence of such remarkable computational power, biomedical discoveries 
entrenched in evolutionary biology may seem impractical. Why study comparative 
biology when one can simply genotype a patient? What is the value of continuing to 
study our evolutionary history when so many diseased phenotypes can be explored 
through computational measures? While genomic technologies have certainly opened up 
a floodgate of research possibilities, we simply cannot forget the value of the model 
organism system, an age-old institution that has provided the very foundation of all that 
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we know in the life sciences. Where would we be today if we had not marveled at the 
simple homology found throughout the animal kingdom?  
  The history of the use of model organisms in the biological sciences dates back to 
the infancy of the scientific method. In his publication Generation of Animals, Greek 
philosopher Aristotle provided numerous written accounts of his use of model organisms 
to study the comparative nature of animal development (Malpas, 2012). Since then, 
rodents, flies, worms, fish, amphibians, primates, and other countless organisms have 
diversified our understanding of the history of life on Earth. Very few subfields have 
relied on the merits of using a model system as intensely as that of developmental 
biology; when, then, did all of this developmental homology (i.e. “sameness”) across 
species begin? 
 
2.2: Urbilateria and the Cambrian Explosion 
Developmental research concerning the morphology of the animal kingdom 
considers the origin of bilateral species as a crucial turning point in evolutionary history. 
Bilateral organisms first appeared on Earth between 535 and 525 million years ago 
during a period known as the “Cambrian Explosion.” At this period in the fossil record, 
species diversification was at a remarkable high (DeRobertis, 2008). While Precambrian 
records include numerous complex organisms, such as that of sponges, radial animals, 
and small bilaterian species, it was not until the Cambrian Explosion that the majority of 
our modern bilateral phyla (levels of organismic classification) became evident and 
valuable to our understanding of animal diversification (Kirschner & Gerhart, 2006).  
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 By the end of the Cambrian era, all but a select few of the modern metazoan 
(multi-cellular) phyla had evolved, as well as each of the thirty major bilateral animal 
phyla. The species that evolved during this period exhibited patterns of increased 
behavioral complexity as compared to their recent ancestral counterparts, supporting the 
notion that the Cambrian explosion was a time of immense evolutionary innovation 
(Knoll & Carroll, 1999). How this period of evolutionary history led to such profound 
diversification remains an enigma; however, the prevailing hypothesis, called the 
“Snowball Earth Scenario,” stipulates that several periods of glaciation between 750 and 
550 million years ago led to the survival of only those species that could survive extreme 
bottlenecking (a type of genetic isolation that leads to a loss in diversity). Upon warming, 
a late Protozoic increase in atmospheric oxygen levels most likely removed the 
environmental barrier that previously had prevented the diversification of bilateral, 
“higher” organisms (DeRobertis, 2008; Knoll & Carroll, 1999).  
 Perhaps the most exciting evolutionary outcome of the Cambrian explosion was 
the emergence of Urbilateria, the last common bilaterian ancestor of all animal species on 
Earth. Paleontological records indicate that Urbilateria emerged around 560 million years 
ago (right before the onset of the Cambrian explosion) and subsequently diverged into 
protostomes and deuterostomes (Kirschner & Gerhart, 2006; DeRobertis, 2008). 
Protostome and deuterostome species differ at one of the earliest stages in development; 
while the oral end of a protostome develops from the first opening of the blastopore 
(opening in the central cavity of an embryo), this same cavity of the deuterostome 
develops from the second opening. Some example protostomes include arthropods, 
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nematodes, and annelids, while deuterostomes include the well-known chordates (which 
later gave rise to the vertebrates). These distinctions represent the first major bifurcation 
in the “Animalia” kingdom, a seemingly small yet vastly important step in the cascade of 
our evolutionary history (Figure 2.1).   
Figure 2.1. Branching of protostomes and deuterostomes from an Urbilaterian ancestor 
and subsequent lineages associated with these two groups. Humans (which are 
vertebrates) fall within the category of “Chordate” and are classified as Deuterostomes. 
Illustrations depict the emergence of diverse bauplan characteristics across the animal 
kingdom, as compared to the original morphology of Urbilateria. Adapted from 
Balavoine & Adoutte, 2003.  
 
Urbilateria has been characterized as a small, worm-like organism. Measuring at 
roughly 1 millimeter in length, it likely featured a through-gut, anterior head, three 
organizational germ layers, and multiple primitive sensory organs. It was also much more 
complex than its radial ancestor and probably housed a primitive nervous system 
(Kirschner & Gerhart, 2006). Inferences about the anatomy and physiology of Urbilateria 
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have been made through comparison of the characteristics present in the various modern 
animal phyla—if a conserved gene is found in both deuterostomes and protostomes, it 
stands to reason that the sequence was also present in the genome of Urbilateria. 
Recently, efforts have been made to computationally reconstruct the Urbilaterian genome 
through the tracing of gene duplications, deletions, and mutations across the larger animal 
phylogenetic tree. It has become evident that Urbilateria’s genome likely featured the 
majority of developmental networks that distinguish the animal kingdom today 
(DeRobertis, 2008).  
 Thanks to comparative genomics, we now know that protostomes and 
deuterostomes share a remarkable number of developmental pathways that trace back to 
Urbilateria and the Cambrian explosion. Some of these pathways include the canonical 
hox genes, a plethora of growth factors, Wnt, the Hedgehog proteins, Notch ligands, and 
various proteins implicated in epidermal-growth factor signaling. These observations 
have supported the hypothesis that Urbilateria was the first organism to contain a 
complete and “modern” animal genome. While we are certainly limited in our reliance on 
extant (currently-living) animal genomes to draw inferences about the first bilateral 
genome, evolutionary biologists have nevertheless come to realize that, from a 
developmental perspective, members of the animal kingdom are highly similar at the 
molecular level (Knoll & Carroll, 1999).   
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2.3: Darwin, Natural Selection, & the Basics of Evolutionary Theory 
In The Descent of Man, Charles Darwin claimed, “man still bears in his bodily 
frame the indelible stamp of his lowly origin” (Shubin, Tabin, & Carroll, 2009). While 
little was known about the molecular basis of heredity at the time of Darwin’s famous 
expedition, he was remarkably prescient in his assertion that all members of the animal 
kingdom must share the fundamental basics of an evolutionary past. When asked why the 
Proterozoic-Cambrian boundary in the paleontological record reflects the sudden 
emergence of immeasurably diverse taxa, Darwin, like countless others, was stumped; 
why has there been so little change in bauplans (body plan morphologies) at the phylum 
and super-phylum levels since the Cambrian explosion, while the opposite has been 
observed within distinct classes (Knoll & Carroll, 1999; Davidson & Erwin, 2006)?  
 Before diving head-first into the robust “deep end” of modern evolutionary 
theory, it is important to consider the role of Darwinian evolution as foundational to all 
aspects of the field. Darwin’s theory of natural selection stipulates that environmental 
constraints act upon individuals in a population such that only those that are most well-
adapted to their environment will effectively reproduce and pass on their genetic 
material. Perhaps the most important element of Darwin’s theory is its realization over 
evolutionary time – as environmental constraints change and become more selective over 
generations, the most “favorable” of phenotypes will accumulate within the gene pool 
and lead to the potential for long-term speciation (Stern & Orgogozo, 2009). At the 
molecular level, it would stand to reason that mutations with pleiotropic effects (genes 
linked to multiple phenotypic outcomes) would be less likely to support long-term 
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adaptivity because of their higher “sensitivity” to dramatic alterations; however, critics of 
the Darwinian model of evolution cite that selection need not be the only method in 
which evolutionary novelty may arise. The neutral theory of molecular evolution 
stipulates that most changes within and between species at the molecular level are in fact 
supported by the genetic drift (random changes in genetic variation in a population) of 
neutral, non-selective alleles (Ohta, 1992). Regardless of these differences, the modern 
perspective on evolution states that biased subsets of random mutations most often 
produce compounded phenotypes specific to various branches along the phylogenetic tree 
of the animal kingdom (Stern & Orgogozo, 2009).  
 The adaptive evolution of diverse species to aquatic, terrestrial, and aerial 
environments lead to the diversification of body plans and the pressing need for 
adaptability within the animal kingdom following the emergence of Urbilateria. 
Historically, evolutionary biologists and paleontologists focused on the homology of limb 
development and the diversification of bauplans within Cambrian records because these 
comparisons could be made with the naked eye. While discovery of the anatomical 
similarities of limb development has certainly shed light on the general patterns of 
homology, it wasn’t until the advent of modern molecular technologies that biologists 
could truly witness the homology of development. Within the context of bauplan 
innovation since the Cambrian explosion, our best clues seem to lie in the developmental 
networks that have formed us all (Shubin & Tabin, 1997).  
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2.4: The History of Biological Homology 
 Since its conception, the evolutionary basis of homology has generated a 
remarkable amount of debate within and among communities of biologists. As of 1994, 
there were nineteen distinct definitions for the phenomenon, each specific to a 
subdiscipline of biology (Hall, 2003). The concept of homology was originally made 
prominent in 1843 by Richard Owen, who defined it as “the same organ in different 
animals under every variety of form and function” (Sansom & Brandon, 2007). As the 
number of studies concerning homologous morphology has grown, so has our collective 
understanding of the relationship between evolutionary time and the emergence of new 
body plans in species on Earth today.  
Historically, biologists based their concept of homology on phenotypic, 
anatomical data directed at the organismic level (Brigandt, 2003; Wagner, 2015). The 
vast majority of these discoveries were grounded in synapomorphies, which are 
characteristics shared exclusively by species that have a common, direct ancestor. 
Biologists who tackled questions concerning homologous features were lumped under the 
subfield category “phylogenetic systematics” (Wake, 2003). Fervent supporters of the 
theory of natural selection, titled “Darwinian biologists,” claimed that two characters 
could only be homologous if the origin of said characters could be explained by descent 
from a common ancestor (Sansom & Brandon, 2007; Amundson, 2005). This concept 
contrasts with that of “analogues,” which are functionally homologous characters that do 
not share origins in a common ancestor (Hall, 2003). Thomas Huxley, a famous English 
biologist, was one of the first scientists to note that many homologous adult structures are 
  
 
14 
more obviously similar when considered during the stages of development (Gilbert, 
Opitz, & Raff, 1996). Richard Owen complicated this observation when he made the 
assertion that descent from a common ancestor is not sufficient to invoke the formation of 
homologous characters; rather, he proposed that two characters can only be homologous 
if they share an underlying mechanism of development (Amundson, 2005). These 
observations and those of developmental biologist Ernst Haeckel led to the creation of the 
famous theory of recapitulation, which states that the successive stages of development 
mirror the stages of evolution in that species’ remote ancestors (Richardson & Keuck, 
2002). While we now understand the inherent flaws in Haeckel’s theory, little could be 
done in these times to test whether the phrase “ontogeny recapitulates phylogeny” was an 
entirely accurate assessment. 
 At the time of its conception, the identification of homologous characters among 
species was considered to be a useful form of “phenotype organization.” We now know 
that studying homology is worth so much more than this—it is a key pattern in which 
evolution gives rise to new species (Wagner, 2015; Wake, 2003). This transition was 
largely influenced by discoveries in the field of molecular genetics. Thomas Hunt 
Morgan, a famous American geneticist and the man responsible for elucidating the role of 
chromosomes in genomic organization, was a proponent of the idea that genetics, rather 
than paleontology alone, is key to understanding the nuances of evolution. He claimed 
that the origins and development of higher taxa could be explained through many of the 
pattern that govern population genetics (Gilbert, Opitz, & Raff, 1996).  
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While different subfields of biology have distinct criteria in which to determine 
whether two characters are homologous, a common definition considers it as an 
“investigative kind concept”—it links objects of the same kind, even if the underlying 
mechanisms that govern said similarities remain unknown (Brigandt, 2003). Studies that 
concern evolutionary homology fall within the categories of genetic homology, 
developmental/ontogenetic homology, and organismic homology, as well as often take a 
taxic or transformational approach to study design (Hall, 2003; Wake, 2003). The taxic 
approach utilizes character and morphological data to make phylogenetic hypotheses, 
while the transformational approach tracks changes in homologous structures over 
evolutionary time and postulates their potential causes (Wake, 2003). Three general 
criteria are often considered in the discernment of homologous characters—these include 
whether they arose in similar positions within the organisms themselves (morphology), 
whether they have identical (or at least similar) functions, and/or whether they have 
similar intermediate and transitory forms during the life cycle (Rutishauser & Moline, 
2005).  
 While much of the original criteria of evolutionary homology remain the same, 
the expansion and diversification of subfields in the biological sciences has led to the 
creation of numerous nuanced definitions. Juggling the differences in homology between 
subfields like genetics, anatomy/physiology, and phylogenetics presents a significant 
challenge for cross-disciplinary studies; however, an even more pressing problem is 
found in the need for selecting an appropriate hierarchical level at which to make such 
analyses (Wake, 2003). This brings up a most difficult and frustrating facet of 
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homology—the simple fact that it is entirely reliant on perspective. An anatomist’s claim 
that two morphological body parts are canonically homologous may, at the molecular 
level, turn out to be entirely false; conversely, a lack of obvious homology at the 
organismic level may in fact hide the presence of a developmental network that is 
remarkably homologous (Hall, 2003). The ambiguous nature of homology, while 
frustrating and exhausting for biologists, remains a beautiful and humbling example of 
how very little we truly know about the patterns of evolution.   
 
2.5: Subfield Definitions of Homology 
As with other evolutionary principles, it comes as no surprise that defining 
homologous patterns between species is dependent on the level of hierarchy utilized by a 
given subfield and study design. Much of our current understanding of canonical, well-
known homologous features is inherently linked to the flexibility in which we may define 
homology itself (Rutishauser & Moline, 2005). While there is no “correct” answer when 
it comes to defining homology, it is intriguing to note that the different subfields often 
define homology within the context of their own field’s bias. A developmental biologist 
will consider homology in a different light than an evolutionary ecologist simply because 
the study of life spans numerous levels of organization.  
 Biological homology, the broadest of subfield definitions, seeks to understand the 
essence and cause of preserving a specific character across time, with the intention of 
discovering why homology is generally favored (Wake, 2003). This definition can be 
subdivided into that of the evolutionary and phylogenetic systematics specifications; 
  
 
17 
while evolutionary biologists consider two elements homologous if they are connected by 
a transformation series of intermediate homologues, phylogenetic systematic biologists 
consider homology as the principle defining characteristic of taxons (another term for 
phylogeny-based organism classifications). In comparative anatomy and physiology, 
characters are deemed homologous only if their relative position in a bauplan share 
similar structural, connective, and/or topological/histological similarities (regardless of a 
potential phylogenetic linkage). When considering the divergent definitions of homology 
in these subfields, it becomes apparent that the term is often defined by the general 
agenda of a group’s study methodologies. Evolutionary biologists are primarily 
concerned with patterns of spatiotemporal speciation, phylogeneticists aim to discover 
the connections between current (rather than extant) species, and anatomists are 
concerned with patterns of body architecture (Brigandt, 2003).  
 Perhaps unsurprisingly, the task of defining homology at the molecular level 
appears to be just as difficult as that of the organismic level. Molecular biologists 
traditionally focus on the homology between molecules across taxa with the intention of 
comparing genetic sequence similarities and protein architecture. This perspective does 
not imply an evolutionary connection; rather, examples of molecular homology often 
consider the origin of entire molecular pathways as key units of evolutionary progress 
(Brigandt, 2003). A common criticism of the molecular approach to defining homology 
cites that some homologous molecules arise from independently-evolved sister taxa 
(termed “lineage splitting). Furthermore, paralogy (the process of gene duplication) can 
give rise to a “pseudo-homologous” network of proteins that in actuality are just 
  
 
18 
replicates of the same protein template. These counter arguments have helped formulate a 
more common definition of molecular/developmental homology, which focuses on the 
genetic and/or developmental basis of shared characters among species. Instead of simply 
focusing on gene families across an organism’s entire life cycle, the zootype model 
stipulates that all species share a master genetic ground plan (dating, of course, to 
Urbilateria) that provides the basis in which homologues may form and evolve, 
irrespective of their mechanism of origin (Wake, 2003).  
 Regardless of these differences among subfields, there are five general levels of 
homology that have been consistently observed in paleontological and molecular records 
of speciation. The first, called historical homology, groups like characters based on 
evidence of their known common origin and ancestry. A canonical example of such a 
character is that of the notochord, a transient, embryonic midline structure that assists in 
ventral fate specification and vertebral development within all chordates (Stemple, 2005). 
These kinds of characters, which often have roots in earlier phylogenetic branches, tend 
to be more “dramatic” examples of the anatomical similarities in animal development. 
Certain subfields (namely that of evolutionary biology) consider this to be the only “true” 
level of homology; however, this rather limited view of homology fails to consider that 
all species are inherently linked by a common ancestor, even if this organism existed 
hundreds of millions of years ago.  
To explain these instances of morphological sameness among related taxa that do 
not share an ancestor with the same trait (and thus do not fit into the historical category of 
homology), biologists have defined what is known as underlying/latent homology. This 
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concept, also termed “parallelism,” is often cited as the “reawakening” of homologous 
developmental mechanisms that simply were silenced in the common ancestor. A 
fascinating example of this phenomenon is found in the parallel evolution of anaerobic 
fermentation in various species of yeast; the Crabtree effect, which considers why yeast 
favor anaerobic fermentation in the presence of abundant oxygen, has been found to have 
evolved independently in two common yeast lineages through the loss of a genomic 
regulatory element implicated in respiration (Rozpędowska et al., 2011).  
The third (and newest) level of homology, called molecular homology, is 
exclusively concerned with the comparison of protein sequences and architectures among 
species (Rutishauser & Moline, 2005). Recently, molecular biologists have realized that 
sequence homology is not sufficient for uncovering all homologous networks; rather, 
similar sequences can in fact elicit different phenotypes in species that are 
phylogenetically disparate (Sansom & Brandon, 2007). The task of parsing molecular 
homologues and relating them to their anatomical outcomes is undeniably arduous.  
 A level of homology that continues to be hotly debated among biologists is that of 
serial homology. This form of homology considers the origin and diversification of 
iterated parts in a single organism over time. An example of this form of homology is 
found in the two sets of limb appendages that are common to many animal species. Also 
called “iterative homology” or “homonomy,” this topic is sometimes excluded from 
discussions of homology because it compares the whole body and its repeating parts, as 
opposed to two organisms or species separately. Without consideration of this form of 
homology, however, developmental biologists would be unable to understand how 
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similar molecular bauplans give rise to repeated elements among species. A crucial 
example of this is found in the consideration of vertebrate somites, which are blocks of 
mesoderm that develop in tandem alongside the neural tube and give rise to the basic 
elements of the vertebral bauplan (such as the dermis, skeletal muscle/tissue, and the 
vertebrae) (DeRuiter, 2010).   
From a developmental perspective, serial homology is absolutely essential to 
“evo-devo”—since a whole organism is built upon its parts, the development of these 
parts must be related to the restrictive governing of the whole. In fact, some of the earliest 
discoveries in developmental homology were linked to instances of serial homology in 
model organism systems, such as that of the hox genes and body axis morphology among 
bilateral species. These transcription factors are conserved throughout the animal 
phylogenetic tree and are responsible for specifying the anterior-posterior body axis 
(Shubin, Tabin, & Carroll, 2009).  
The hox genes, a canonical example of the functional consequences of molecular 
homology, are also an example of the fifth and final category of homology—that of deep 
homology. Deep homology compares divergent taxa that have conserved molecular and 
developmental mechanisms yet do not have homologous corresponding phenotypes. This 
is where Urbilateria and the evo-devo toolkit become relevant; comparisons of species at 
opposite ends of the phylogenetic tree, such as arthropods versus vertebrates, are nearly 
impossible unless one considers that Urbilateria’s genetic regulatory apparatus has left an 
important handprint on each of our genomes. Perhaps the most fundamental question of 
evolutionary development thus asks—do morphological homologies have the same 
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underlying molecular genetic machinery, given one approaches the problem from the 
right level of perspective (Rustishauser & Moline, 2005; Shubin, Tabin, & Carroll, 
2009)? 
 While each of the subfields certainly provide valuable insights into the nuances of 
homologous features, it is the perspective afforded by developmental biologists that most 
thoroughly integrates the organismic and molecular influences on evolutionary 
homology. Phenotype and morphology alone are not enough to reveal the mechanisms 
behind character conservation; rather, comparison of the developmental networks 
employed by vastly divergent species hints at the presence of an ancient regulatory circuit 
that, given the right perspective, makes everything homologous (Shubin, Tabin, & 
Carroll, 2009). Instead of producing developmental networks de novo at each junction in 
the phylogenetic tree, evolution seems to have optimized those networks that simply 
“work.” Yet again, it appears as if homology is entirely dependent on perspective.  
 
2.6: Homology vs. Homoplasy—Is There Actually a Difference? 
Another popular and controversial evolutionary term that tends to complicate the 
definition of homology across subfields is that of “homoplasy.” Put broadly, homoplastic 
characters are morphological and/or molecular phenotypes shared by two species that are 
absent in their most recent common ancestor. Traditional evolutionary biologists prefer to 
classify homoplasy as “false homology” because, from a phylogenetic perspective, the 
derived similarity is not the result of obvious and immediate common ancestry (Wake, 
2003). A canonical example of homoplasy in the animal kingdom compares the 
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appearance of wings in bird and bat species; considering that the most recent common 
ancestor of these species did not have wing-like appendages, this indicates that the 
homology witnessed between these species must have been attained via different 
phylogenetic routes (Shubin, Tabin, & Carroll, 2009).  
 The evolution of novel appendages, such as that of bird and bat wings, can be 
categorized into three general evolutionary pathways—that of divergent evolution, 
parallel evolution, and convergent evolution. Divergent evolution occurs when different 
traits can be traced back to the same source, such as the tracing of human arms and bat 
wings to a common mammalian ancestor (Shubin, Tabin, & Carroll, 2009). Parallel 
evolution occurs when the same trait evolves independently in different species and can 
be traced back to a distinct ancestral trait; a great example of this is found in the 
comparison of similar adaptive traits in marsupials and placental mammals, even though 
the evolutionary environments of these species were vastly different (Hall, 2003). Finally, 
as the direct antithesis to divergent evolution, convergent evolution occurs when similar 
traits evolve and yet cannot be traced back to a common ancestor. The most dramatic 
example of convergence implicates, once again, the evolution of wings in the animal 
kingdom; even though birds, bats, and insects diverged a remarkably long time ago, it 
appears as if wings were advantageous enough that evolution decided to favor their 
selection more than once (Shubin, Tabin, & Carroll, 2009).  
There are also documented instances of traits having evolved via convergent 
evolution in species that share a not-so-distant ancestor. In Old World monkeys, 
trichromatic color vision is dependent on the presence and expression of multiple opsin 
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genes, whereas most New World monkeys have only one opsin gene. Due to these 
differences, new world males are dichromatic and only females with a different copy of 
the opsin gene on the X chromosome are trichromatic. Interestingly, howler monkeys 
(new world) support trichromatic vision in both sexes, indicating that gene duplication in 
this species evolved in the same manner as that of the Old World monkeys. Unlike their 
New World counterparts, trichromatic vision in howler monkeys appears to have evolved 
via convergent evolution with that of Old World primates, such as macaques, baboons, 
and mandrills (Jacobs, Neitz, Deegan, & Neitz, 1996).  
If certain morphological characteristics witnessed across the phylogenetic tree 
tend to reappear across evolutionary time, even without a common ancestor that had the 
trait in question, then where did the trait originally come from? Do convergent characters 
arrive de novo with each branching of the tree, or is there something deeply homologous, 
especially at the molecular level, that allows such traits to “appear” in later, further 
adapted progeny species? Should we look far back enough, it may be that parallel and 
convergent characters arise from the scaffolding of deeply homologous sequences that 
date back to the original animal genome. When considered from the perspective of 
homology as opposed to homoplasy, characters such as these may be examples of “latent 
homology” in which previously silenced (but ever-present) developmental programs 
become active once more (Hall 2003).  
 What does homoplastic evolution look like from a molecular and genetic 
perspective, as compared to that of the more canonical, anatomical examples? Molecular 
parallelism tends to occur via the accumulation of small changes in homologous genes 
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over long stretches of time, such as through single amino acid mutations (Stern & 
Orgogozo, 2009). When considered in conjunction with the phenotypic outcomes of such 
evolutionary events, parallelism implicates Urbilateria’s deeply homologous 
developmental network as a potential evolutionary constraint (DeRobertis, 2008). It is 
possible that the regulatory mechanism “template” that originated in Urbilateria’s 
genome is what allows parallel characteristics to emerge at different evolutionary times, 
even if the mechanism remains “dormant” in one species for a longer period than another 
(Shubin, Tabin & Carroll, 2009). This logic holds true when considering the molecular 
origins of convergent characteristics as well—we expect convergent characteristics to 
have different underlying development mechanisms unless we can determine that the 
origin of said “mystery” characteristic was actually contained in the ancestral genome 
long before it was outwardly expressed (Hall, 2003).  
A notable example of the relationship between the evolution of similar 
phenotypes in dramatically different species and their corresponding molecular 
morphologies considers the evolution of echolocation in bats and whale species. 
Echolocation, which is the ability to locate a target object through the use of reflective 
sound waves, is made possible by microscopic cilia (hair-like structures) found in the 
inner ear. Cilia are known to predate all mammals, and yet a certain “version” of the 
prestin protein, which is critical for sensitive hearing, is unique to the bat and whale 
lineages. When compared to other organisms that produce prestin protein and do not have 
the ability to echolocate, the protein sequences of bat and whale species share a unique 
structure simply because they evolved the same protein function (Venema, 2013). 
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Examples such as this in the animal kingdom open up the possibility that, given the right 
genetic predisposition and the right environmental pressures, speciation at the molecular 
level may be entirely dependent on the broader principles of homology.  
 
2.7: Descent with Modification—a Molecular Consideration of Evolution 
While it is true that many of our claims about the homologous pathways 
contained in Urbilateria’s genome involve conjecture, discoveries in comparative 
genomics have indicated that, at the molecular level, homologous proteins provide a 
framework with which we may sequentially reconstruct the “original” animal genome. It 
is shocking that we share so much of our genomes with that of other species; for 
example, humans and fruit flies share sixty percent of their coding genes, even though 
their anatomy and physiology would lend one to believe that such is not a possibility! It is 
foolish to think that evolution carefully hand-crafted each and every animal genome at all 
of the phylogenetic junctions; instead, deeply homologous networks and their resulting 
morphologies have supported independent innovation across evolutionary time. While 
millions of years of evolution cannot be broken down to a single biological pattern, it 
would seem as if the perpetual persistence of deeply homologous networks has attested to 
their utility and robustness in supporting large-scale speciation (Hall, 2012).  
Should evolution thus be characterized as the collaboration of deliberate, careful 
patterns of craftsmanship, or instead as a “hands-off, trial-and-error” set of environmental 
innovations? The latter model of evolution, called “Descent with Modification” by 
Charles Darwin, stipulates that speciation is the result of subtle modifications within the 
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confines of environmental and selective pressures (Shubin, Tabin, & Carroll, 2009; Stern 
& Orgonzo, 2009). This perception of evolution is often contrasted with an image of 
selection as the result of “bursts” of entirely de novo innovation. At the molecular level, it 
is probable that exposure to similar environmental cues has allowed already diverged 
species to become “activated” in a specific regulatory network across evolutionary time, 
even when these regulatory networks have lain phenotypically dormant. From this 
framework, phenomena like homoplastic characters become nothing more than nuanced 
examples of biological homology (Hall, 2003). Taking such a broad perspective allows 
one to see that quiescent molecular phenotypes have the potential to give rise to 
homologous organismic phenotypes, given that the right environmental pressures are 
exploited. This concept also aligns with the theory of punctuated equilibrium, which 
considers periods of stasis along the phylogenetic tree to be of evolutionary relevance. 
Speciation may have occurred through sudden “bursts” at specific spots in the fossil 
record simply because the right environmental pressures at that geological time activated 
favorable, latent pathways (Gould & Eldridge, 1993).  
While our understanding of evolutionary homology is certainly limited because 
multicellular organisms have been forced to retain the same basic “building blocks” in 
order to successfully evolve, this does not detract from the notion that homologous 
characters have been favored because of their adaptability and favorability across time. 
Each time a new phenotype arises in the timeline of evolution, it is considered an 
evolutionary novelty; however, it is not until that novelty transitions into homology that it 
can be truly considered a favorable trait (Wagner, 2015).  
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2.8: The Clues Found in Developmental Homology 
Along with ascribing to a more robust definition of homology, the field of 
evolutionary development is unique in that it focuses on those molecular pathways that 
are exceptionally common among members of the animal kingdom. Comparative studies 
of animal anatomy during development indicate that phenotypic divergence is more or 
less linearly correlated with time—at the beginning of development, embryos from 
different species are almost entirely indistinguishable. While phenotypic and molecular 
divergence among animal species becomes markedly more pronounced after 
development, the “reawakening” of developmental pathways later in life (whether 
through normal or abhorrent mechanisms) provokes evolutionary biologists to consider 
how developmentally homologous networks can impact adult homeostasis. Evo-devo 
uniquely explains how structures can emerge in ontogeny (development), why they 
appear and function as they are, as well as why and how they have been conserved and 
transformed through phylogeny by integrating molecular and anatomical data (Brigandt, 
2003; Hall, 2012). In the quest to distinguish real versus superficial homology among 
comparative species, evo-devo takes a unique approach by formulating a more concrete 
picture of homology; instead of speculating about the origin of homologous characters, 
evolutionary developmental biologists have the opportunity to inspect all levels of animal 
organization such that the underlying mechanisms of our “sameness” become readily 
apparent (Wagner, 2015).  
 Before considering the molecular mechanisms in which protein evolution has 
shaped the homology of animal development, it is important to ask how evo-devo 
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grapples with the problem of integrating molecular and organismic data on homologous 
features. There is no denying that the molecular and anatomical definitions for homology 
are often difficult to translate, leading to subfield-specific definitions that exclude broader 
criteria; however, one could also argue that it is the non-biased exploration of how 
molecular phenotypes directly create anatomical phenotypes during development that sets 
evo-devo’s definition of homology apart. Evolutionary development is also uniquely able 
to assess the role of intra-organismic homologies (such as that of serial homology) within 
the broader scope of evolutionary development. Through the integration of molecular and 
anatomical data on homologous characters, evolutionary developmental biologists are 
able to uniquely construct wholistic depictions of the plausible constraints that led to the 
diversification of Urbilateria’s genome, a topic which will be explored in the next chapter 
(Brigandt, 2003; Sansom & Brandon, 2007).  
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Chapter 3 
THE HOMOLOGOUS PATTERNS OF DEVELOPMENT 
 
3.1: Introduction 
 Developmental biologists are uniquely primed for studies concerning homology—
in the quest to understand how form meets function, embryologists must be intimately 
familiar with the mechanisms in which molecular processes translate into organismic 
phenotypes. We have already seen how different perspectives of biological inquiry may 
give rise to varied definitions of homologous characters; unlike other fields of the life 
sciences, however, evo-devo biologists possess the most impartial tools for understanding 
the many levels of animal homology within the context of evolutionary novelty. With a 
concept so open to interpretation, it would seem as if studying homology at any level of 
animal organization (let alone across all of them) would be a tremendous feat—how, 
then, do evo-devo biologists do it?  
 
3.2: The Time-Honored Exploitation of Genetic Material 
 In order to understand the vantage point from which evo-devo biologists compare 
the spatiotemporal patterns that govern animal development, it is important to understand 
the general facets of embryogenesis that are shared by all species (Hoekstra & Coyne, 
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2007). There is no question that development on the whole is intricately complex at both 
the molecular and anatomical levels; however, as organ systems become established, the 
molecular mechanisms that govern animal embryogenesis tend to become more nuanced 
and species-specific. Regulatory processes at the onset of development are often 
comparatively less complex and have a more dramatic pleiotropic effect on phenotype 
because they establish the basis of bauplan architecture—thus, the beginning and middle 
stages of development are where we find the majority of homologous molecular networks 
(Davidson & Erwin, 2006). These patterns, coupled with the claim that changes in 
genomic regulation act as key drivers of evolution, potentially explain how homologous 
characters develop on a molecular scale (Hoesktra & Coyne, 2007).  
 It would stand to reason that a species with a larger genome should be more 
phenotypically complex than that of a small genome. While this pattern is certainly 
evident across the larger tree of life, there are numerous instances in which genome size 
does not positively correlate with phenotypic complexity (Levine & Tijan, 2003). 
Considering that the biochemical signaling cascades important to cell functionality tend 
to be rather large and complex, small changes in an organism’s genome often lead to 
exponentially large phenotypic consequences (Hoekstra & Coyne, 2007). This 
relationship between an organism’s genome and biochemistry further implicates the role 
of regulatory elements in evolutionary novelty. A telling example of how animal 
complexity has been achieved through changes in genomic regulation lies in a 
comparison of the nematode Caenorhabditis elegans and the common fruit fly 
(Drosophila melanogaster); C. elegans, a phenotypically simple animal, has a genome 
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comprised of roughly 20,000 genes, while that of D. melanogaster (a more complex 
organism) features only 14,000 genes. Furthermore, the human genome contains 
approximately 20,000 genes, and yet there is little question as to whether or not we 
feature more dynamic tissue systems than that of a worm (Levine & Tijan, 2003)! 
 If increasing phenotypic complexity through speciation is not always positively 
correlated with the size of an organism’s protein-coding genome, then how has evolution 
“exploited” such a small number of genes, many of which can be traced back to 
Urbilateria’s genome? Previously, two mechanisms of diversification have been proposed 
by molecular biologists—that of alternative splicing and DNA rearrangement. In the 
process of creating mRNA, the molecule that directs protein synthesis in the cell, a single 
stretch of genomic material has the potential to code for numerous proteins via the 
mechanism of alternative splicing, thus allowing for a smaller genome to code for a 
larger proteome (Levine & Tijan, 2003). A rather dramatic example of this phenomena is 
found in the D. melanogaster genome, which features a gene called dscam that directs 
neuron pathfinding and codes for roughly 18,000 different proteins in a single stretch of 
base pairs (Kashyap & Tripathi, 2008). The other proposed mechanism, simply described 
as “DNA rearrangement,” encompasses those mutational events in which various parts of 
the genome rearrange in sequential order and frequency such that spatiotemporal 
expression levels of various proteins becomes more complex over evolutionary time.  
Increases in physiological and behavioral complexity along the phylogenetic tree 
have been largely accredited to evolutionary changes in the expression of genes, rather 
than changes in the number of protein-coding genes themselves. The mechanisms that 
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describe many of these changes are cis-regulatory sequences and the diversification of 
multi-protein transcription complexes, two processes that will be explored in depth later 
in this chapter (Levine & Tijan, 2003). When examining the evolutionary history of 
complex developmental traits, it is important to keep in mind that the appearance of 
favorable characters is largely determined by what is possible at the molecular level, what 
is probable within the genomic constraints situated in an animal’s genome, and what is 
permissible via selective environmental pressures (Carroll, 2008). It is likely that the 
accumulation of slight genomic alterations over evolutionary time has given rise to the 
many distinct phenotypic traits associated with extant species on earth today (Stern & 
Orgogozo, 2009).   
 
3.3: The Structure of the Protein-Coding Genome 
 Before diving into the molecular mechanisms that have given rise to 
diversification throughout the animal kingdom, it is important to understand how the 
genome is organized and regulated. Only two percent of the metazoan genome 
(multicellular, eukaryotic organisms) features protein-coding sequences; besides those 
conserved repeat sequences that have unknown functions, the rest of the genome most 
likely contains information for the many types of regulatory mechanisms characteristic of 
higher organisms. It is estimated that a third of the animal genome codes for cis-
regulatory sequences that direct the binding of regulatory molecules implicated in 
spatiotemporal gene expression. These sequences are connected to the larger processes of 
chromosome condensation, pairing, segregation, and expression patterning. In higher 
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organisms, each protein-coding gene contains ten kilo-base pairs of DNA on average, 
with only a fraction of these nucleotides comprising the gene itself. Ascidiacea, a 
phylogenetic class that includes simple sea squirts, have an estimated ten to twenty-
thousand tissue-specific regulatory sequences called enhancers, even though they are 
phenotypically simple organisms (Levine & Tijan, 2003).  
 Out of the two percent of the metazoan protein-coding genome, five to ten percent 
of coding capacity is dedicated to producing proteins that directly regulate transcription. 
These proteins include many classes of sequence-specific DNA binding proteins, such as 
transcription factors, large multi-protein RNA polymerase chain complexes, and 
countless chromatin remodeling complexes. Protein-coding genes are traditionally 
organized into four parts—first, a sequence called an enhancer flanks the front of the 
gene (a cis-regulatory element, may also be found after the gene body) and is responsible 
for binding transcription factors; next lies the promoter, a sequence which, upon upstream 
binding of transcription factors, supports the binding of RNA-polymerase and the 
activation of transcription; third lies the sequence that directly codes for the protein in 
question; and finally, there is a termination in the coding sequence and the potential for 
another cis-regulatory element called a silencer, which can bind to other regulatory 
molecules and conversely downregulate transcription of the gene in question. Another 
cis-regulatory element that adds a layer of complexity to genome expression is that of an 
insulator; while the relative occurrence of insulators in the human genome remains 
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unknown, insulators are known to inhibit the binding of enhancers and silencers through 
spatial constriction of the 3D architecture of DNA (Raab & Kamakaka, 2010).  
 
Figure 3.1. Schematic of the general architecture of a protein-coding gene. Regulatory 
sequences upstream and downstream of the transcription start site (depicted in yellow) 
are locations of transcription factor binding, which leads to differential patterns of 
expression. The gene body, depicted in red, features the sequence of nucleotides 
responsible for the eventual production of the protein in question. Adapted from Shafee 
& Lowe, 2017.  
 
Most animal genes have multiple enhancers that are located before or after protein 
coding sequences. Sometimes found within the introns (parts of the gene that are excised 
after transcription) of a gene itself, they help to direct spatiotemporal patterns of 
transcription without directly altering the mRNA’s code. Normally, an enhancer is 
dedicated to the direct activation of a gene in a tissue-specific manner such that the 
expression of a protein may look dramatically different in one tissue system as compared 
to another. Enhancers often have multiple sites for transcription factor binding and 
sometimes couple these regulatory activities with the use of multiple promoter sequences 
(Buecker & Wysocka, 2012). In the early stages of development, embryos must transition 
from utilizing mom’s “pre-loaded” transcription factors and signaling molecules to those 
that it assembles itself; compared to other protein-coding sequences, these genes 
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disproportionately rely on more than one promoter. The complexity of these regulatory 
networks is made even more pronounced when multi-subunit cofactor complexes are 
considered, as these conglomerates of proteins require the binding of multiple proteins to 
invoke silencing and/or transcriptional enhancement activity. Upon considering these 
factors, it appears as if phylogenetic complexity is directly related to transcriptional 
plasticity; while the yeast genome, the simplest of eukaryotic organisms, contains 
approximately three hundred sequences coding for transcription factors, the genomes of 
C. elegans and D. melanogaster contain over one thousand transcription factors (Levine 
& Tijan, 2003).  
 When comparing species-specific exomes, which include only protein-coding 
sequences and ignore cis-regulatory elements, it appears as if proteins have remained 
remarkably homologous over evolutionary time. This has allowed molecular and 
evolutionary biologists to track the evolution of protein “families” and their comparative 
phenotypes across species. While molecular function seems to be relatively consistent 
along the phylogenetic tree, phenotypic function can vary dramatically. The disruption of 
developmental genes often leads to the appearance of unique phenotypes that, without 
molecular comparisons, appear to be entirely divergent. It is possible that upon knockout 
of specific genes, phenotypic outcomes may vary simply because each species supports 
its own cell signaling networks with proteins that are implicated in unique biochemical 
“steps” of a network. A current dilemma in evo-devo lies in the need for laboratory 
methodologies that concretely recognize equivalent molecular phenotypes between 
different model organisms, even if these phenotypes may not share the same anatomical 
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outcomes. These phenotypes, deemed “phenologs,” are often related by the orthology 
(spatiotemporal development) of associated genes in two different organisms, suggesting 
that evolutionarily conserved characters can sometimes convergently arise through 
different disruptions of the same set of conserved genes. These challenges recapitulate 
the need in evo-devo studies to reconcile examples of homology at both the molecular 
and organismic levels (McGary et al., 2010).  
 More recently, studies concerning comparative protein domains and sequence 
conservation have indicated that homology at the molecular level does not always 
translate to shared phenotypic characters (and vice versa). A protein domain is a 
conserved stretch of amino acids that is shared among proteins in similar families and 
classes. Canonical, well-known examples of protein domains that are shared among 
functionally-similar proteins include kinase domains and cytoplasmic domains, only two 
groups of over fifty-three million unique examples in the animal kingdom. Domain-
specific studies are often used as tools in modern genomics and developmental biology 
because they discretely identify homologous functions between two proteins. It is not 
surprising that proteins with the same domain composition are likely to be ancestrally 
related; however, like almost every other example of molecular homology, there are 
instances in which some comparative proteins feature similar sequences with different 
domains (and vice versa). The study of protein evolution, just like the study of evo-devo, 
is not clear-cut, and even though it is hypothesized that close to all of the protein families 
contained in the animal genome today originated from a small number of domains, there 
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is still much work to do in uncovering just how similar our protein-coding genome is to 
that of Urbilateria’s (Caetono-Anolles, 2011). 
 
3.4: The Mutations that Altered Ubilateria’s Genome 
When it comes to understanding those parts of the animal genome that have been 
selectively altered over the course of evolutionary time, it is important to understand that 
conserved mutations are not always equally distributed. Even though each mutational 
event is itself random, segments of the genome that are repeatedly and preferentially 
mutated, termed “hotspot genes,” disproportionately belong in the category of 
developmental regulatory proteins. Of this group of protein-coding segments, those that 
are deeply homologous (i.e. deep conservation across species) tend to be patterning genes 
that dictate development in more than one cell type. It is perhaps no surprise, then, that 
many of our canonical examples of deeply homologous sequences contain families of 
transcription factors that function within large protein networks in the earliest stages of 
animal development (Stern & Orgogozo, 2009).  
If sections of an animal’s exome are thus preferentially targeted for evolutionary 
innovation, are there certain types of mutational events that are also under positive 
selection? The five types of mutations that most likely gave rise to the alteration and 
diversification of Urbilateria’s genome include that of structural mutations, gene 
expansions, gene duplications, gene deletions, and cis-regulatory mutations. The first of 
these includes all alterations of the genome in which the order of specific protein-coding 
segments is changed. While these mutations do not affect the protein’s functionality per 
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se, they do alter the spatiotemporal expression of that protein in relation to its neighbors. 
This type of mutation becomes important when a protein is translocated and placed on a 
non-synonymous chromosome; in this novel location, the spatiotemporal transcription of 
the protein may become differentially upregulated or downregulated based on the 
expression patterns of its new neighbors (DeRobertis, 2008).  
A similar phenotypic effect to structural mutations is found in gene duplications 
and expansions. In duplication events (and in its large-scale version, dubbed gene 
expansions), the emergence of multiple copies of a protein allows the subsequent 
mutation and innovation of one copy without loss of the original sequence (and thus its 
original functionality). Duplications and expansions are often favored in large families of 
transcription factors such that many developmental regulatory networks may contain 
some degree of functional overlap. In the sea urchin genome, for example, there are 
hundreds of duplicated protein-coding sequences for Toll-like receptors and leucine-rich 
proteins that helped support the diversification of autoimmunity across species. In most 
developmental cases, duplications and expansions have either allowed the tandem 
duplication of protein exons or have supported increased opportunity for alternative 
splicing (DeRobertis, 2008).  
The direct antithesis to gene duplications and expansions is that of gene deletions. 
In regard to evolutionary innovation, gene deletions are often utilized as molecular 
adaptations to new ecological niches through immediate loss of protein function. This 
type of mutational event is comparatively dramatic—from a developmental perspective, 
these mutations can lead to the loss of whole organs, such as eye degradation and 
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subsequent development of albinism in cave-dwelling salamanders. A rather extreme and 
fascinating example of the loss of an entire developmental system through gene deletion 
is found in the disappearance of segmentation patterns in nematode and planarian 
flatworm species, even though their common ancestor was undoubtedly a segmented 
organism (DeRobertis, 2008).  
The final type of mutational event that led to the diversification of Urbilateria’s 
genome was that of cis-regulatory mutations. In the spirit of Neo-Darwinian natural 
selection, these mutations are likely to have had a dramatic impact on animal 
diversification and innovation across evolution because they can support the subtle 
compounding of small regulatory alterations over time. Unlike structural mutations, 
duplications, expansions, and deletions, cis-regulatory mutations do not require novel 
mutations in coding regions to be “tested out” for positive functionality. Due to their role 
in regulation, a single-point mutation in a cis regulatory region (CRE) has the capacity to 
single-handedly impact the spatiotemporal expression of unrelated proteins in numerous 
divergent regulatory networks. CREs provide the ultimate platform for evolutionary 
innovation—by mutating a single CRE, the genome is able to alter its ability to bind a 
target transcription factor, which has the potential to exponentially change the regulation 
of an entire cascade of proteins without directly affecting any of these proteins, including 
that of the original transcription factor (DeRobertis, 2008; Levine & Tijan, 2003).  
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3.5: The Lewis Model & Hox Genes—How Duplication Diversified the Metazoan Body 
Plans 
 Perhaps the most remarkable step in the evolution of species on earth was that of 
the emergence of multicellular organization. In order to step out of the limitations of 
unicellularity, molecular innovation needed to acquire the capacity to support cell-type 
divergence and coordination. Much of our understanding of the evolutionary 
development of metazoans depends on the study of sponges, the most ancient and 
primitive multicellular organisms still on earth today (Coutinho et al., 2003). For a body 
part to develop, the domain (location) of that part must be specified at the molecular 
level, followed by the morphological patterning that gives rise to such a phenotype. 
Comparative studies have indicated that the coordinated development of body plans 
among all animal bauplans dates back to regulatory mechanisms contained in 
Urbilateria’s genome (Davidson & Erwin, 2006).  
 Perhaps the most canonical example of how gene duplications have driven the 
homologous patterns of animal development lies in the Homeobox genes, a group of 
proteins that direct body axis development (Akam, 1989). Studies concerning the 
Homeobox genes largely propelled the field of developmental biology into the spotlight 
of biomedical inquiry. Hox genes were first discovered as master control genes in D. 
melanogaster and were later identified in other vertebrate model systems (Carroll, 2008).  
As developmental directors of cell fate, proliferation, and diversification, Hox genes act 
as transcription factors that preferentially bind to target cis-regulatory elements and 
initiate developmental cascades related to body segmentation and limb development. 
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Even sponges, which retain a relatively amorphous bauplan, have genomes that contain 
the Hox genes efh-1 and prox2, indicating that these sequences are deeply homologous 
(Coutinho et al., 2003; Akam, 1989).   
 If Hox genes were present in Urbilateria’s genome, then through which mutational 
mechanisms did they help diversify the animal kingdom? A comparison of Hox copy 
number in the genomes of D. melanogaster (fruit fly), D. rerio (zebrafish), and M. 
musculus (mouse) indicate that these homeotic genes were diversified through 
duplication and subsequent diversification events. Contrary to cis-regulatory mutations, 
Hox genes serve as an example of the Lewis Model, which contends that genetic 
innovation across evolutionary time has been principally achieved through the 
employment of duplication events (Gehring, 1998). Besides this increase in copy number, 
which has led to the emergence of different Hox frequencies across the phylogenetic tree, 
Hox transcription factors are also unique in their spatiotemporal expression during 
development. Hox genes in all model organism systems are expressed in a reverse 
collinear relationship called the “Hox clock”—genes that are expressed earlier in 
development and are at the 3’ chromosomal position are related to anterior axis 
specification, while those that are expressed later in development and at 5’ chromosomal 
positions direct posterior processes (Shubin, Tabin, & Carroll, 2009; Akram, 1989). This 
order of expression relates to the temporal and spatial coordination of stem cell 
differentiation in developing embryos, as the collinearity of the Hox genes allows Wnt 
signaling to induce axial progenitor cells to direct spatial coordinates (Deschamps & 
Duboule, 2017). By duplicating and then “tweaking” these transcription factors along the 
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phylogenetic tree, it seems as if evolution has allowed for the slow and steady 
diversification of body axis patterning within the confines of selective constraints.  
 Besides the duplication and diversification of individual Hox genes within 
species, comparison of the mouse and fruit fly genomes (representing that of 
invertebrates and vertebrates) indicate that vertebrates also experienced whole group 
duplications of these genes. The groups, called “Hox clusters,” also seem to follow a 
linear pattern of regulation—entire clusters are often co-expressed in a 3’-5’ fashion 
along their location on a given chromosome. The regulatory use of these clusters in 
tandem with the collinear pattern of individual gene expression provides a narrative for 
the developmental diversification of vertebrates, as this additional layer of regulatory 
complexity follows species along the phylogenetic tree. Regardless of regulatory 
differences, perhaps the most surprising characteristic of Hox genes is that they exhibit 
acute sequence similarities, regardless of species diversification. Later in development, 
comparative roles of the genes across species indicate that they support analogous (rather 
than homologous) phenotypes at the organismic level (Akam, 1989). It is absolutely 
remarkable that  unique combinations of sequence conservation, individual gene 
duplications, and cluster duplications were able to give rise to such a robust family of 
deeply homologous transcription factors; Hox genes, like many other examples of 
evolutionary novelty in development, further implicate Darwin’s notion that evolution 
functions via descent with modification.  
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3.6: The Homologous Regulatory Patterns of Evo-Devo 
 While the single-protein mutational perspective certainly sheds light on the 
patterns of selective pressure that have guided speciation at the molecular level, the study 
of evolutionary animal development would not be complete without a consideration of 
the selection that has dictated which cellular protein networks have stood the test of time. 
Homology is not solely observable from the microscopic view of singular genes and their 
coded proteins; rather, it appears that homologous networks are also often found in 
examples of the comparative cellular regulatory machinery that direct animal 
development. Pleiotropy, ancestral genetic complexity, functional equivalence, 
heterotropy, and cis-regulatory elements are the most common mechanisms in which 
homologous protein networks have driven animal diversification over time (Carroll, 
2008).  
 One major challenge in uncovering the evolutionary origins of important 
developmental protein networks has been in answering the question of how two identical 
proteins are capable of giving rise to different phenotypic outcomes in comparative 
species. Homologous examples of pleiotropy, a term to describe instances in which a 
single locus affects multiple traits, are unique in evo-devo simply because the vast 
majority of developmental proteins participate in numerous independent pathways. The 
use of pleiotropic loci in development logically coincides with that of the “descent with 
modification” theory of evolutionary novelty—instead of repeatedly supporting a de novo 
creation of proteins to accommodate selective pressures, evolution has favored the 
integration of master regulatory proteins into new networks over time (Carroll, 2008). An 
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example of a protein that is known to give rise to vastly divergent phenotypes at the intra-
organismic level is that of Sonic hedgehog—this protein is known to play a role in the 
networks that govern neurulation, digit polarity and number, floor plate development, and 
even feather bud formation (McMahon, Ingham, & Tabin, 2003). Proteins such as this are 
often deemed “mosaic” because they play integral roles outside of the confines of a single 
cell type or germ layer and function as conserved toolkit proteins. While individual 
proteins in the same developmental networks across species may not share direct 
sequence conservation, it appears as if proteins like Hedgehog act as a conserved 
example of the homology contained in master regulators (Carroll, 2008).  
 The second pattern observed among homologous developmental protein networks 
considers the notion of ancestral gene complexity. In this category falls the Hox genes; 
like other large developmental gene families, the Hox proteins are remarkably similar 
among vertebrates and invertebrates. The vast majority of ancestral gene families are 
made up of transcription factors, which further indicates that speciation at the molecular 
level has been shaped by small changes in the animal regulatory genome (rather than 
through quick and large genome changes). When considering toolkit proteins and their 
ancient origins, it is important to note that many of these proteins, if replaced by an 
orthologous protein from a vastly divergent species, are capable of “taking over” and 
directing normal development. Murine Pax6, a transcription factor that directs eye 
development, is able to direct normal ommatidium formation in both its host species and 
in Drosophila, indicating that the protein has not been dramatically altered since chordate 
divergence. Examples of functional equivalence such as this indicate that there must have 
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been considerable evolutionary constraints enacted upon these specific proteins over time 
and that much of the basic animal machinery is homologous across phenotypically 
diverse animal species (Carroll, 2008). It is possible that we are unable to elucidate the 
exact mechanisms that gave rise to these toolkit proteins simply because they predate 
Urbilateria itself.  
 Contrary to other large gene families, duplications of prominent toolkit proteins 
have been observed at a surprisingly low frequency on average. While it was previously 
thought that protein innovation is always preceded by gene duplication, studies of master 
regulators like the Hox family have found that no new Hox members have arisen in the 
mammalian lineage. Interestingly, the tetrapod lineage has actually lost some Hox 
members over time. A possible explanation as to why duplication is not a prerequisite for 
novelty within this subset of proteins implicates the dosage-sensitivity of most 
developmental processes (Carroll, 2008).  
 The final two patterns observed across homologous protein networks in 
development include that of heterotropy and cis-regulatory diversification. From a 
developmental context, heterotropy is a term to describe comparative spatial changes in 
development across evolutionarily related species. A conceptual example of this can be 
found in the different limb locations of mammals; these morphological changes are often 
not caused by different molecular players themselves, but rather are enacted by different 
mechanisms of spatiotemporal gene expression during key stages of development. This 
points to the role of cis-regulatory elements in initiating cascade-effects on protein 
networks, considering that cis-regulatory elements allow the accumulation of small 
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mutations over time without disrupting toolkit sensitivity. All toolkit transcription factors, 
with their plethora of molecular functions in a developing embryo, are inherently at the 
mercy of multiple modular cis-regulatory elements that have the potential to tweak their 
activity at distinct time points in development. Again, the notion of descent with 
modification comes into play—instead of invoking dramatic, protein-specific mutations, 
selection has the potential to both maintain chromatin stability and “tinker” with CREs 
(Carroll, 2008).  
 While these homologous regulatory patterns make conceptual sense when 
considered on their own, how can these collective patterns provide a holistic explanation 
of evolutionary development at the intermolecular level? In 2006, Davidson and Erwin 
constructed a machine learning algorithm to answer this exact question. They postulated 
that homologous master regulators that govern animal body plan development (such as 
the Hox family of transcription factors) function as “evolutionarily inflexible 
subcircuits,” i.e. they perform essential upstream functions that are vital to viable 
embryonic development, while “certain small subcircuits” act as developmental signaling 
proteins (often not homologous across species) that are smaller “plug-ins” for networks. 
These smaller players, which they later titled “gene regulatory network (GRN) kernels,” 
have been co-opted repeatedly by selection to take on diverse developmental purposes. 
When combined, their proposed “kernel architecture” indicates that evolutionary 
innovation through the diversification of animal development is governed by both the 
conserved master regulators at the top of the kernel and the lower plug-in proteins that 
are amenable to alteration over time (Davidson & Erwin, 2006).  
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 According to their algorithm, there are distinct properties that govern whether or 
not a GRN kernel is evolutionarily feasible from the perspective of body plan innovation. 
First, their model stipulates that genes at the top of the protein cascades were almost 
always master transcription factors. Second, they determined that besides executing the 
spatial commands for the development of a given body part, the smaller kernels were 
dedicated to a specific temporal location during development and did not execute any 
other function. Finally, and perhaps most intriguingly, they found that the proteins within 
the kernels had to be continually transcribed for the kernel to continue functioning (a 
positive feedback loop). Interference with the first kernel proteins would inevitably result 
in the destruction of the kernel’s function altogether. These combined observations led to 
the computational confirmation of a long-accepted concept in evo-devo—that protein 
networks are conserved across development to the point of being categorized as deeply 
homologous (Davidson & Erwin, 2006). Future investigations into the homologous 
patterns of evolutionary development through computational approaches may be key to 
understanding how homology has shaped animal novelty.   
 
3.7: Are Cis-Regulatory Elements the Missing Link? 
 There remains much to be explored on how cis-regulatory elements (CREs) drive 
development and impact the preservation of homologous protein networks across 
evolutionary time. The prevailing hypothesis considers whether mutations in CREs can 
enact a genomic “snowball” effect—upon mutation, important transcription factors may 
differentially bind to target CRE elements and support varied patterns of gene expression 
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and protein translation. Interestingly, most novel CREs in extant animal genomes have 
been found to arise via transposition, a type of copy number variation in which a whole 
section of the genome is relocated to a new chromosomal location. These transposable 
elements are under uniform selective pressure, indicating that transposons may act as 
primitive CREs that change the spatiotemporal expression of a cascade of proteins. Loss-
of-function mutations in CREs have also been observed to downregulate entire networks 
of development, further implicating the snowball effect of these regulatory elements. 
Perhaps the most exciting facet of CRE modification is that they have the potential to 
alter pathways in a variety of mechanistic directions, such that evolutionary novelty may 
arise through a plethora of epigenetic forms (Carroll, 2008).  
With only two percent of the human genome coding for proteins, it comes as no 
surprise that much of cellular functionality depends on the spatiotemporal control of gene 
expression. Is it realistic to hypothesize that small, accumulated changes in cis regulatory 
elements could account for the magnitude of evolutionary innovation seen in fossil 
records since the emergence of Urbilateria? While there is little doubt that homologous 
CREs during development certainly impacted the long-term interplay between speciation 
and phylogenetic branching, it is not likely that they alone can account for the 
diversification of the animal kingdom. Instead, it is probable that structural and 
regulatory mutations have supported speciation since the Cambrian explosion. A major 
criticism of evolutionary development in recent years has cited that evo-devo research 
focuses too heavily on the homologous patterns of body plan morphology; instead, the 
missing link between structural and regulatory mutations may be found in the study of 
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homologous behaviors, metabolisms, and physiologies of comparative species. While the 
study of form versus function is certainly more feasible when consulting fossil records, 
the advent of modern molecular technologies has opened up the opportunity to consider 
just how much of the modern animal bauplan is dependent on the interplay of structure 
and regulation (Hoekstra & Coyne, 2007).  
 
3.8: Transcription Factors & the Regulation Conundrum 
 As was validated in Davidson & Erwin’s machine learning model on the nature of 
protein networks in driving homologous patterns of development, it is well-known that 
transcription factors play a substantial role in cell functionality and differentiation 
(Davidson & Erwin, 2006). Compared to other major groups of proteins, transcription 
factors tend to be conserved in structure and function because they are tasked with the job 
of maintaining protein scaffolding and timed expression. Because they interact with 
CREs and other regulatory enzymes, transcription factors hint at a potential mechanism 
in which small mutational events bifurcate and multiply differential gene expression 
across evolutionary time. It is foolish to assume that changes in epigenetic regulation can 
account for all of the important novelty in the animal phylogeny; however, through the 
“radical co-option of function” afforded by transcription factors and their corresponding 
CREs, the animal genome may well have accumulated selectively favorable mutations 
over time (Hoekstra & Coyne, 2007). When considered at the molecular level and 
beyond, these sorts of mutations give meaning to the comparative types of homology 
discussed in chapter two—if homology did not exist at the most basic molecular level, 
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biologists would most certainly struggle in finding examples today of organismic 
homology that inspired previous generations to coin the term.   
 
 
3.9: Chapter Three References 
 
Akam, M. (1989). Hox and HOM: homologous gene clusters in insects and vertebrates. 
Cell, 57(3), 347-349. 
Buecker, C., & Wysocka, J. (2012). Enhancers as information integration hubs in 
development: lessons from genomics. Trends in Genetics, 28(6), 276-284. 
Caetano-Anollés, G. (2011). Evolutionary genomics and systems biology. John Wiley & 
Sons. 
Carroll, S. B. (2008). Evo-devo and an expanding evolutionary synthesis: a genetic 
theory of morphological evolution. Cell, 134(1), 25-36. 
Coutinho, C. C., Fonseca, R. N., Mansure, J. J. C., & Borojevic, R. (2003). Early steps in 
the evolution of multicellularity: deep structural and functional homologies 
among homeobox genes in sponges and higher metazoans. Mechanisms of 
Development, 120(4), 429-440. 
Davidson, E. H., & Erwin, D. H. (2006). Gene regulatory networks and the evolution of 
animal body plans. Science, 311(5762), 796-800. 
Deschamps, J., & Duboule, D. (2017). Embryonic timing, axial stem cells, chromatin 
dynamics, and the Hox clock. Genes & development, 31(14), 1406-1416.  
De Robertis, E. M. (2008). Evo-devo: variations on ancestral themes. Cell, 132(2), 185-
195. 
  
 
54 
Gehring, W. J. (1998). Master control genes in development and evolution: The 
homeobox story. Yale University Press. 
Hoekstra, H. E., & Coyne, J. A. (2007). The locus of evolution: evo devo and the genetics 
of adaptation. Evolution: International Journal of Organic Evolution, 61(5), 995-
1016. 
Kashyap, L. & Tripathi, P. (2008). Alternative splicing: how one gene can make many 
proteins. Bioscience, 4(1), n.p.  
Levine, M., & Tjian, R. (2003). Transcription regulation and animal diversity. Nature, 
424(6945), 147. 
McGary, K. L., Park, T. J., Woods, J. O., Cha, H. J., Wallingford, J. B., & Marcotte, E. 
M. (2010). Systematic discovery of nonobvious human disease models through 
orthologous phenotypes. Proceedings of the National Academy of Sciences, 
107(14), 6544-6549. 
McMahon, A.P., Ingham, P.W., and Tabin, C.J. (2003). Developmental roles and clinical 
significance of hedgehog signaling. Curr. Top. Dev. Biol. 53, 1–114. 
Raab, J. R., & Kamakaka, R. T. (2010). Insulators and promoters: closer than we think. 
Nature Reviews Genetics, 11(6), 439.  
Shafee, T., & Lowe, R. (2017). Eukaryotic and prokaryotic gene structure. WikiJournal 
of Medicine, 4(1), 2. 
Shubin, N., Tabin, C., & Carroll, S. (2009). Deep homology and the origins of 
evolutionary novelty. Nature, 457(7231), 818. 
  
 
55 
Stern, D. L., & Orgogozo, V. (2009). Is genetic evolution predictable? Science, 
323(5915), 746-751. 
 
  
  
 
56 
 
 
 
Chapter 4 
HOMOLOGY IN ACTION – A PAC CASE STUDY 
 
4.1: The Homology of the ETS Family 
The Hox genes and Pax6 function as canonical, well-known examples of deeply 
homologous proteins in development—as drivers of body plan morphology, they have 
functioned as excellent tools in bridging the gap between older anatomical studies in 
fossil records and that of newer molecular investigations. But what about less well-
known examples of molecular homology during the later stages of animal development, 
specifically those in which families of transcription factors drive tissue-specific 
development?   
Unlike other canonical examples of deeply homologous sequences, the ETS 
family of transcription factors has not been as thoroughly explored from an evolutionary 
perspective. In terms of embryogenesis, members of the ETS family function as master 
transcription factors in the development of the animal circulatory system across species. 
Most research to date on these proteins depicts the biochemical parameters that govern 
them as a distinct group. Originally named after the E26 transformation-specific family in 
the avian erythroblastosis virus, the ETS family of transcription factors features 11 
distinct subfamilies that have been conserved across a remarkably wide array of species. 
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The subfamilies are primarily differentiated based on their subdomain compositions and 
the position of the DNA-binding domain within their primary sequences (Sato, 2001). In 
accordance with other homologous transcription factors, ETS homologs have been 
identified in mice, fish, worms, flies, and humans, with most of these proteins acting as 
transcriptional activators and/or repressors. At the subcellular level, ETS variants have 
been implicated in cell migration, differentiation, and proliferation during development 
and adulthood (Craig & Sumanas, 2016). Interestingly, the ETS family was originally 
used as a model for understanding general transcriptional control and has helped 
elucidate the epigenetic mechanisms that determine tissue differentiation in model 
organism systems (Graves & Peterson, 1998). At least thirteen of these transcription 
factors have been identified as molecular players in hematopoietic (blood cell) and 
endothelial (blood vessels) stem cell differentiation (Craig & Sumanas, 2016).  
ETS transcription factors (TFs) can be easily classified through careful 
observation of their similar architectures and sequence homology. Each TF features a 
conserved “ETS” domain made up of 85 amino acids which has a low-complexity 
binding target of the GCA sequence motif; this relatively small and simple motif 
highlights the potential functional plasticity of this family such that ETS proteins may 
have a wide array of targets (Craig & Sumanas, 2016). In Ets1, the binding domain is 
near the C-terminus, while in Elf1 it resides in the middle of the sequence and at the N-
terminus in Elk and Sap1. Rather surprisingly, this family of transcription factors lacks 
the canonical helix-turn-helix motif for substrate binding that is found in most other TF 
families. ETS family members can also bind to a wide array of multi-subunit complexes, 
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suggesting that there are likely other regulatory mechanisms that these proteins may 
participate in. The different ETS subfamilies likely arose via multiple gene duplication 
events, as Fli/Ets1 and Erg/Ets2 are closely linked on separate chromosomes. The 
presence of very similar homologs in Drosophila melanogaster (fruit flies, invertebrates) 
and humans (vertebrates) suggests that these gene duplications were likely ancient events 
(Wasylyk, Hahn, & Giovane, 1994). There is a possibility that there is also some 
functional overlap between ETS members within individual organisms, and studies 
generating knockouts of these genes must often consider the multiple homologs present 
in each model organism genome (Craig & Sumanas, 2016).  
While the ETS family of transcription factors may not be an obvious choice for 
the study of evolutionary developmental homology, it is important to consider examples 
of molecular homology outside of the traditional focus of body plan morphology. As key 
regulators of vascular development, ETS proteins serve as a unique example of how 
master regulatory molecules specific to the development of individual organ systems may 
further complicate our understanding of the general facets of animal homology. In the 
summer of 2018, I was fortunate to have worked in Dr. Saulius’ Sumanas’ laboratory on 
a project that focused on the ETS family of proteins in zebrafish vascular development. 
Model organism systems such as that of Danio rerio provide an excellent opportunity for 
biological researchers to consider how homology has impacted our own species’ 
evolution and health.  
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Identification of a Novel Vascular Endothelial Progenitor Cell Population in Danio rerio 
 
4.2: Project Introduction 
Vertebrate vascular development functions as a remarkable example of the 
diverse molecular mechanisms that support embryogenesis. As one of the first organ 
systems to fully develop, the vascular system is tasked with directing gas exchange and 
nutrient acquisition throughout an organism’s lifetime. Many studies concerning these 
processes have used Danio rerio as a model species; while blood circulation commences 
at roughly 24hpf (hours post- fertilization), zebrafish embryos do not rely on circulation 
until much later in development. This morphological characteristic gives researchers the 
opportunity to observe phenotypic mutants that would otherwise perish prematurely 
(Ellertsdottir et al., 2010).  
Vascular development in vertebrates is temporally governed by two broad 
mechanisms—that of vasculogenesis and angiogenesis. Vasculogenesis, the first step in 
vessel formation, is the de novo assembly of primary blood vessels from angioblasts, a 
progenitor population of cells derived from the posterior lateral plate mesoderm 
(Sumanas & Lin, 2005; Ellertsdottir et al., 2010). In response to Sonic Hedgehog (SHH) 
and VEGF signaling, angioblasts migrate bilaterally to the embryonic midline and 
coalesce, forming the dorsal aorta (DA) and posterior cardinal vein (PCV) (Casie Chetty 
et al., 2018; Ellertdottir et al., 2010). These cellular movements occur in two waves, with 
the first giving rise to the dorsal aorta and the second to the cardinal vein (Figure 4.1). 
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Specification of arterial versus venous fates is accomplished before vasculogenesis is 
complete (Kohli et al., 2013).  
 
 
 
Figure 4.1. Angioblast migration during vasculogenesis. (Top) The primordial formation 
of the dorsal aorta occurs before that of the posterior cardinal vein. Cells in red depict the 
first wave of progenitor cells migrating and coalescing to form the dorsal aorta, while 
blue cells depict the second wave that give rise to the posterior cardinal vein. (Bottom) 
SHH and VEGF gradients instruct arterial and venous angioblasts to migrate bilaterally. 
The top, purple structure represents the notochord, the middle represents the expression 
gradient of SHH, and the sides represent the expression gradients for VEGF. Red cells 
depict DA progenitor populations, while blue cells depict PCV progenitors. Adapted 
from Casie Chetty et al., 2018.   
 
At roughly 22hpf, angiogenesis begins to take over as the primary mechanism of 
blood vessel formation in the zebrafish trunk. Unlike vasculogenesis, angiogenesis is the 
elaboration of the vasculature from the scaffolding of pre-existing vessels. Angiogenesis 
begins when aortic sprouts migrate dorsally and form the aortic intersegmental vessels 
(ISVs). In keeping with the two-wave model of angioblast movement, cells from the 
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posterior cardinal vein sprout later than those from the dorsal aorta (Figure 4.2). 
Interestingly, sprouts from the PCV are not restricted to a segmental fate; instead, they 
may contribute to the lymphatic vasculature or migrate ventrally to become the 
subintestinal vasculature (Casie Chetty et al., 2018). It is currently thought that after the 
primary vessels have formed in the trunk, all new vessels thereafter are formed 
exclusively via angiogenesis; it is not clear, however, if new vascular progenitors are 
capable of incorporating into the existing vasculature at this time in development.  
 
 
 
Figure 4.2. Timeline of angiogenic sprouting from the Dorsal Aorta (DA) and Posterior 
Cardinal Vein (PCV). After the establishment of the DA and PCV following 
vasculogenesis, sprouts first migrate out of the DA at 22-23hpf, followed by those from 
the PCV at about 32-34hpf. The Dorsal Longitudinal Anastomotic Vessel and associated 
segmental vessels/veins are established in the trunk vasculature by around 2 days post 
fertilization. SA: Segmental Artery; SV: Segmental Vein; DLAV: Dorsal Longitudinal 
Anastomotic Vessel. Adapted from Ellertsdottir et al., 2010.  
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Figure 4.3. The major vessels of the zebrafish trunk at 48hpf. H: Heart; CCV: Common 
Cardinal Veins; DA: Dorsal Aorta; PCV: Posterior Cardinal Vein; SV: Segmental Vein; 
SA: Segmental Artery; DLAV: Dorsal Longitudinal Anastomotic Vessel; ISV: 
Intersegmental Vessels; CA: Caudal Aorta; CV: Caudal Vein. Adapted from Bolcome et 
al., 2008.  
  
At the molecular level, several important TFs have been implicated in the regulation 
of vasculogenesis and angiogenesis. One such regulatory molecule is etv2; this member of 
the ETS family of transcription factors has been shown to direct the early differentiation of 
vascular endothelial cells in the zebrafish trunk beginning at the 10-somite stage (Sumanas 
& Lin, 2005). etv2 expression in the vasculature generally decreases at 24hpf; however, 
our laboratory has demonstrated that a population of progenitor cells exhibit high 
expression of this TF between 24 and 48hpf. Our laboratory named these cells 
“Pronephros-associated cells” (PACs) due to their proximity to the pronephros (primitive 
kidney) (Figure 4.4).  
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Figure 4.4. PACs expression of etv2 in the zebrafish trunk. Whole-mount in situ 
hybridization imaging of wild type expression at 24, 30, and 36hpf. Red arrows indicate 
locations of PACs in the trunk at corresponding time points. DA: Dorsal Aorta; PCV: 
Posterior Cardinal Vein. Images courtesy of Sanjeev Metikala, Sumanas Lab, Cincinnati 
Children’s Hospital Department of Developmental Biology.  
 
PACs are most numerous in the embryonic trunk between 32hpf and 38hpf (Figure 
4.5). Upon migration into the midline, time-lapse imaging indicates that PACs appear in 
the yolk extension and subsequently integrate into the PCV. Remarkably, this integration 
mechanism leaves blood circulation uninterrupted (Figure 4.6). Besides etv2, PACs also 
express other canonical vascular endothelial progenitor markers, such as lmo2 (Lim 
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domain only 2) and scl (T-cell acute lymphocytic leukemia 1) (Figure 4.6). While useful 
in elucidating their role as a progenitor population, these markers are not PAC-specific, as 
etv2 is a general vascular regulator, scl is a known hematopoietic marker, and lmo2 is 
expressed in macrophages. We currently do not have a marker that is exclusive to PACs; 
however, upon analysis of bulk RNA-seq analysis and subsequent observation of 
expression in the yolk extension at 30hpf, jam2b (a junctional adhesion molecule) has been 
implicated as a potential regulatory molecule for PACs (Figure 4.7).  
 
 
Figure 4.5. Histogram of average number of PACs per embryo at various stages of 
zebrafish embryonic development. Error bars represent +/- 1 standard deviation. Data 
courtesy of Andrew Koenig and Sanjeev Metikala, Sumanas Lab, Cincinnati Children’s 
Hospital Department of Developmental Biology.  
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Figure 4.6. Illustration of PAC integration into the PCV. Figure courtesy of Sanjeev 
Metikala, Sumanas Lab, Cincinnati Children’s Hospital Department of Developmental 
Biology.  
 
 
Figure 4.7. scl, lmo2, and jam2b expression in the yolk extension. scl and lmo2 are both 
expressed in PACs at 30hpf. Expression of jam2b at 30hpf is exclusively localized to the 
yolk extension, the same location as PACs at this stage in zebrafish development. Images 
courtesy of Sanjeev Metikala, Sumanas Lab, Cincinnati Children’s Hospital Department 
of Developmental Biology. 
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Due to their behavior as a progenitor population, our lab hypothesized that PACs 
are capable of giving rise to new endothelial cells in the zebrafish vasculature. In this 
project, we investigated if PACs are capable of repopulating the trunk vasculature, as well 
as whether integration is vessel-specific. Furthermore, we predicted that jam2b is a 
molecular regulator of PACs because of its spatiotemporal expression in the yolk extension 
at 30 hpf. We aimed to elucidate if jam2b loss-of-function affects PAC frequency in the 
trunk.  
 
4.3: Conditional Cell Ablation- Methodology 
In order to investigate whether PACs are capable of giving rise to new endothelial 
cells upon integration into the major trunk vessels, targeted cell ablation (death) was 
induced in vascular cells. Traditional methods of invoking cell-specific apoptosis include 
surgery, laser-mediated ablation, and the creation of transgenic lines with DTA (dipthera-
toxin A); however, many of these techniques are labor-intensive, time-consuming, and 
hard to reproduce in a large number of embryos (Curado et al., 2009).  
A novel method for conditional ablation that has been optimized in D. rerio is the 
NTR-MTZ method. This protocol capitalizes on E. coli nitroreductase (NTR), an enzyme 
that catalyzes the conversion of the nontoxic prodrug metronidazole (MTZ) into a 
cytotoxic substrate. The NTR method uses engineered, transgenic lines to sequester the 
MTZ conversion effect to a target population of cells (Figure 4.8); for our experiment, we 
inserted the NTR gene under an etv2 promoter in an etv2:Gal4 line, giving rise to the 
Tg(etv2:Gal4, UAS:gfp, UA:ntr-mCherry) genotype (Curado et al., 2009). Upon MTZ 
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treatment, we thus expected to observe that all vascular cells had been ablated before 
“rescue,” i.e. removal of treatment.  
Transgenic organisms, such as those in our specific reporter line, are organisms 
that have experienced some form of genomic alteration. In a developmental laboratory 
that utilizes a live model organism system, it is imperative that specific cells (such as 
those of the zebrafish vasculature) can be visualized apart from those of other tissues in 
an actively growing organism. gfp, a gene derived from jellyfish that produces a 
fluorescent product when expressed in other organisms, has become an excellent tool for 
accomplishing such a task. When placed under the promoter of a regulatory transcript 
that is expressed in a unique cell type, it allows for the fluorescent detection of target 
cells in an otherwise incoherent biological landscape (Amsterdam, Lin, Moss, & 
Hopkins, 1996). In the case of our transcriptional reporter line, gfp was placed under the 
promoter of etv2 because this ETS family member is exclusively expressed in vascular 
progenitor cells during specific developmental time points of interest. When visualized 
under a fluorescent compound microscope, cells expressing GFP will glow and highlight 
those cells that are specific to the vascular system (Figure 4.8).  
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Figure 4.8. Experimental Design for the NTR-MTZ method of targeted cell ablation in D. 
rerio. (A) Schematic of template transgene for a cell-specific promoter (tsp: transcription 
start point; FP: fluorescent protein). (B-C) Using a cell-specific promoter allows for 
conditional ablation and leaves bystander populations untouched in transgenic embryos. 
Figure adapted from Curado et al., 2007.  
 
 
In order to acquire the necessary quantities of embryos within the Tg(etv2:Gal4, 
UAS:gfp, UA:ntr-mCherry) for our experimental purposes, males and females of the 
same etv2:gal4/UAS:ntr-mcherry genotype were sorted for mating once a week. Eggs 
were collected from tanks and stored in fish water (60µg/ml salt water) at 28.5°C, which 
is the optimum temperature for embryo development. Once the embryos reached 50% 
epiboly (about 6 hpf), MTZ treatment commenced. Epiboly is one of the major types of 
cell movements that occur during gastrulation, an early phase in animal development in 
which a single-layered embryo becomes reorganized into multiple germ layers. At 50% 
epiboly, hemangioblasts begin to differentiate and prepare for the onset of etv2 
expression, a beginning marker of the onset of vasculogenesis (Casie Chetty et al., 2018).  
Embryos were allowed to continue developing under the MTZ treatment 
conditions until developmental characteristics consistent with 24hpf were observed; at 
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this time, MTZ treatment solution was replaced with DMSO fish water (a control 
solution) and eggs were returned to the incubator. Fluorescence imaging of live embryos 
was conducted at 38hpf and 60hpf within the following days, followed by corresponding 
in situ hybridization fixation.   
In situ hybridization (ISH) is a widely-used experimental protocol that allows for 
the targeted visualization of a specific transcript (mRNA) within a fixed 
organism/embryo. We utilized ISH to supplement our fluorescence imaging because it 
allows for the observance of a target transcript’s expression at an arrested stage of 
development. For this histological protocol, we utilized an etv2 probe and imaged the 
expression of this transcription factor in embryos fixed at 38hpf and 60hpf under a bright 
field compound microscope (procedure adapted from Thisse & Thisse, 2008).  
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Figure 4.9. Workflow diagram of MTZ treatment outcomes in transgenic embryos versus 
controls in our experiment.  
 
4.4: Conditional Cell Ablation- Results 
Before investigating the rescued phenotype in the Tg(etv2:Gal4, UAS:gfp, 
UA:ntr-mCherry) line, we optimized the concentration of MTZ needed for complete 
vascular ablation. While MTZ is not known to induce dramatic side effects in treated 
zebrafish embryos, we did note that treatment incurred a developmental delay of 1-3 
hours within the majority of our embryos, suggesting a potential for toxic side effects. An 
initial concentration of 2.5 mM MTZ led to reasonable vascular ablation; however, 
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embryos showed traces of vascular cells that had escaped the effect, suggesting that this 
concentration was too low for the 38-hour treatment cycle. We determined that 10 mM 
MTZ solution was sufficient to induce ablation without incurring toxic side effects to the 
embryos, as deemed by whether the embryos were able to reach wild-type developmental 
milestones within the expected margin of time (Figure 4.10).  
Upon rescue from MTZ treatment at 44hpf, embryos were placed in 0.2% DMSO 
(a control solution without any treatment) until 60-64hpf. Fluorescence imaging indicated 
that new endothelial cells appeared in the primary trunk vessels after treatment had been 
removed. This was confirmed through etv2-mediated ISH, as PACs are the only cells 
remaining in the vasculature at 64hpf that express this vasculogenic TF. Furthermore, 
because PACs arrive in the zebrafish trunk later on in development and are a progenitor 
population, they are more likely to escape MTZ-mediated ablation and regenerate (Figure 
4.11a-b). Time-lapse imaging is needed to confirm that these endothelial cells are entirely 
derived from PACs within this region of the vasculature.   
After witnessing the migration of new endothelial cells into the ablated zebrafish 
vasculature post-rescue at 66hpf, we were curious as to whether these cells integrated into 
the posterior cardinal vein, dorsal aorta, and subintestinal vasculature non-randomly.  
These cells appeared to favor migration into the regions of the dorsal aorta and cardinal 
vein over that of the subintestinal vasculature, although replication of these results 
through time-lapse imaging would be needed to confirm this observation (Figure 4.11c).  
 
  
 
72 
 
 
Figure 4.10. 10mM MTZ is sufficient to induce complete vascular ablation. Fluorescent 
and ISH imaging of control, 2.5mM MTZ treated, and 10mM MTZ treated embryos from 
the Tg(etv2:GAL4, UAS:gfp, UAS:ntr-mCherry) transgenic line. Embryos were subjected 
to treatment from 6hpf (50% epiboly) until 44hpf (roughly 38-40 hours of treatment was 
necessary to induce complete vascular ablation in the trunk vasculature). While 2.5mM 
MTZ treatment does not incur complete vascular ablation, 10mM MTZ appears to be 
sufficiently concentrated. Red arrowheads correspond to example PACs following ISH 
under the three experimental conditions. SIV: Subintestinal Vein; PCV: Posterior 
Cardinal Vein; DA: Dorsal Aorta; ISV: Intersegmental Vessels; DLAV: Dorsal 
Longitudinal Anastomotic Vessel.  
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Figure 4.11. Vascular ablation and recovery 
allow new endothelial cells to emerge. (A) 
Fluorescent and ISH imaging of control and 10 
mM MTZ treated embryos from the 
Tg(etv2:GAL4, UAS:gfp, UAS:ntr-mCherry) 
transgenic line. Rescue was performed via 
replacement of MTZ-treated fish water with 
0.2% DMSO fish water. (A-B) Upon MTZ 
treatment, PACs (arrowheads) are the only 
cells in the trunk vasculature because they 
appear later in development. At 60-64hpf, new 
endothelial cells (elongated cells, red arrows) 
appear in the trunk after removal of MTZ 
treatment. (C) Observed location of new 
endothelial cells post MTZ-recovery at 66hpf. 
Cell location (PCV, DA, subintestinal) 
determined by comparison with control of the 
same age. SIV: Subintestinal Vein; PCV: 
Posterior Cardinal Vein; DA: Dorsal Aorta; 
ISV: Intersegmental Vessels; DLAV: Dorsal 
Longitudinal Anastomotic Vessel. 
 
[C] 
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4.5:  jam2b, A Potential Regulatory Molecule for PACs- Methodology 
In an effort to identify a molecular regulator for PACs, our laboratory performed 
single-cell RNA sequencing analysis on vascular progenitor cells in an etv2 transgenic 
reporter line. Embryos were collected at the 15-20 somite stage (development time point 
in which angioblasts migrate bilaterally to the embryonic midline and coalesce) and were 
subjected to Fluorescence-activated cell sorting for the vascular endothelial progenitor 
subpopulation (Figure 4.12). Single-cell sequencing results included jam2b as an 
upregulated differentially-expressed gene in this population; ISH using a jam2b probe 
demonstrated that jam2b is expressed in the yolk extension at the same developmental 
time as PACs (30hpf, see Figure 4.7). Due to this spatiotemporal pattern of jam2b 
expression at 30hpf, we hypothesized that jam2b is a molecular regulator of PACs. We 
utilized a morpholino injection methodology to quantitatively vary the amount of jam2b 
expression in another transgenic line.  
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Figure 4.12. RNA-sequencing analysis in vascular progenitors implicates jam2b as a 
potential regulator of PACs. Embryos were collected at the 15-20 somite stage and 
subjected to FAC sorting for etv2:gfp expressing cells.  
 
 Contrary to the MTZ methodology, embryos from the fli1 reporter line Tg(fli1-
UAS:gfp) (another TF specific to vascular endothelial cells) were subjected to 
morpholino injection following early-morning collection. A morpholino is an oligomer 
molecule that is used by molecular biologists to conditionally “knockdown” the 
expression of a given transcript; through the injection of a morpholino, which is 
complementary to the messenger RNA for this protein, molecular biologists are able to 
alter the spatiotemporal expression of jam2b in model organisms. Morpholinos have been 
widely used in zebrafish conditional knockdown studies because these embryos are large 
in size, transparent, and amenable to injection. Our morpholino included a red fluorescent 
dye (phenol red) such that successful injection could be observed under a compound 
microscope (MO injection methodologies adapted from Nasevicius & Ekker, 2000).  
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 Following morpholino injection between 1 and 2hpf, eggs were placed at 28.5 °C. 
Inspection and fluorescent imaging of injected embryos as compared to controls occurred 
periodically between 24hpf and 48hpf (time span in which PAC integration into the trunk 
vasculature is most frequent). Fluorescent imaging and subsequent confirmation via ISH 
were conducted at 24hpf, 36hpf, and 48hpf with morpholino injection concentrations at 
0.5 ng, 0.75 ng, and 1.5 ng.  
 
4.6:  jam2b, A Potential Regulatory Molecule for PACs- Results 
 Much like the MTZ-mediated ablation protocol, higher concentrations of 
morpholino have the potential to incur debilitating cytotoxic effects for developing 
zebrafish embryos. For this reason, we considered the side effects of injecting a jam2b 
MO at concentrations of 0.5 ng, 0.75 ng, and 1.5 ng. We noted the anatomical 
characteristics of each batch of embryos from the same transgenic line and reported any 
physical deformities and delayed development compared to that of same-age controls. 
We noticed that jam2b knockdown had a more significant effect on both vascular and 
general development in the later stages; while high concentrations (1.5 ng) incurred tail 
deformities at 24hpf, these deformities were comparatively more numerous at 36hpf. 
Furthermore, we found that a high dosage at 1.5 ng led (on average) to a four-hour 
developmental delay. For these reasons, we optimized the morpholino injection at a low 
dosage of 0.5 ng for future studies concerning PAC depletion in the trunk vasculature; at 
this concentration, treated embryos had markedly diminished trunk vasculatures 
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compared to that of their control counterparts, yet did not feature major tail deformities 
and significant developmental delays.  
 In congruence with our hypothesis, jam2b loss-of-function negatively affects PAC 
counts in the trunk vasculature at 24hpf, 36hpf, and 48hpf. At higher dosages of 0.75 ng 
and 1.5 ng, the trunk vasculature was either delayed or incomplete at these time points; 
however, at 0.5 ng, angiogenic timing of sprouting from the dorsal aorta and posterior 
cardinal vein aligned with that of the control embryos. Control embryos at each of the 
three collection points featured higher PAC counts on average compared to their treated 
counterparts. Furthermore, we observed more PACs overall in embryos at 36hpf than 
24hpf. These results suggest that even a low-dosage knockdown of JAM2B function 
affects PAC proliferation in the trunk vasculature to a statistically significant extent. 
jam2b thus remains a promising candidate regulator of PACs (Figure 4.13).  
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Figure 4.13. jam2b loss-of-function negatively affects 
PACs (arrowheads). Fluorescent and ISH imaging of 
control and jam2b MO injected embryos from the 
Tg(fli1a:gfp) line. (A) A morpholino dose of 1.5 ng 
leads to pronounced vascular defects and 
developmental delay in injected embryos (~4 hour 
delay). (B) A morpholino dose of 0.75 ng induces 
moderate vascular defects and some developmental 
delay (~1.5 hours). (C-D) A low jam2b morpholino 
dose (0.5 ng) is enough to decrease PAC frequency in 
the trunk at 24hpf and 36hpf without significantly 
affecting the vasculature. (***) = p-value<0.0005. 
Error bars represent +/- 1 standard deviation. SIV: 
Subintestinal Vein; PCV: Posterior Cardinal Vein; 
DA: Dorsal Aorta; ISV: Intersegmental Vessels; 
DLAV: Dorsal Longitudinal Anastomotic Vessel.  
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4.7:  Discussion & Future Directions 
 While time-lapse imaging is needed to confirm if the migratory endothelial cells 
following MTZ ablation are derived from PACs, the presence of these cells in the 
vasculature between 38 and 60hfp suggests that vasculogenesis remains an important 
mechanism even after angiogenic sprouting has commenced in the trunk. As per the MTZ 
methodology, the only cells that could possibly escape complete ablation between these 
developmental time points would be the PACs. Due to their late migration into the trunk 
and potential for regeneration as a progenitor population, it is possible that the observed 
endothelial cells at 60hpf are nothing more than differentiated daughter cells of the PAC 
population. Previously, it was thought that the completion of vasculogenesis linearly gives 
rise to the onset of angiogenic sprouting in the trunk vasculature; however, our data suggest 
that endothelial integration into the posterior cardinal vein occurs well after blood 
circulation has commenced via a distinctly vasculogenic pattern of migration (Casie Chetty 
et al., 2018).  
 ISH analysis using vessel-specific markers is needed to confirm whether these 
migratory endothelial cells favor integration into the dorsal aorta, posterior cardinal vein, 
or subintestinal lymphatic vasculature following MTZ-mediated ablation. flt4 (fms-related 
tyrosine kinase), a venous marker, cldn5 (claudin 5), an arterial marker, and lyve1 
(lymphatic vessel endothelial hyaluronic receptor 1), a lymphatic marker, are all potential 
candidate probes for use in an ISH protocol following MTZ ablation. Future 
experimentation is also needed to consider if complete vascular ablation following 10 mM 
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MTZ treatment is complete for all etv2-expressing endothelial cells by 24, 30, and 36hpf, 
rather than as late as 44hpf.  
 The etv2 expression profile and late migratory patterns of PACs have allowed for 
the isolation of PAC cells from other vascular cell populations in the zebrafish trunk; 
however, future studies concerning these cells would benefit from the knowledge of a 
potential regulatory molecule specific to their unique transcriptome. The confirmation of 
jam2b as a PAC-specific regulatory molecule after 30hpf, as well as the optimization of 
jam2b morpholino injection concentration, will allow for easier identification of the unique 
PAC identity. Even at the low dosage of 0.5 ng, jam2b morpholino injection reduces the 
frequency of PACs in the trunk vasculature by half; this optimized model allows for the 
isolation of PAC functionality without a significant inhibition of normal vascular 
development.  
 With this optimized morpholino injection methodology in mind, we aim to 
determine if jam2b knockdown affects the number of endothelial cells that integrate into 
the vasculature at later stages in development. If PAC counts are significantly diminished 
in the trunk vasculature even after low-concentration jam2b MO injections, it is possible 
that injected embryos will experience vessel defects in the later stages of development, 
such as through diminished blood flow capacity and vessel leakage. Furthermore, we hope 
to use our morpholino methodology to determine if jam2b knockdown significantly affects 
the comparative diameters of the dorsal aorta and posterior cardinal vein to that of wild-
type embryos in the same transgenic line.  
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 Since PAC cells have previously remained as an unidentified population of 
progenitor cells in the zebrafish vasculature, there is no research to date on whether these 
cells appear in a murine model; however, considering the basic homology of vascular 
development across the animal kingdom, PACs certainly have the potential to become 
therapeutic targets should they prove to be important late-stage migratory cells in the 
mammalian vasculature. The high expression of etv2 during the earliest stages of 
vasculogenesis and in PACs at the beginning of angiogenesis also further implicates the 
ETS family of transcription factors as molecular bridges between basic and translational 
hematopoietic research.   
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Chapter 5 
THE BIOMEDICAL IMPLICATIONS OF VASCULAR HOMOLOGY 
 
5.1: Introduction 
 Perhaps one of the most difficult tasks for biomedical researchers today is the 
challenge of linking basic scientific discoveries with potential therapeutics. While the use 
of homologous animal models for studying complex human diseases continues to serve 
us well, we still have much work to do in connecting bench discoveries to biomedical 
advances. For example, it is certainly relevant to study the nuanced molecular 
mechanisms that drive zebrafish vasculogenesis and angiogenesis simply for the sake of 
understanding this model organism system; however, it is not until we have taken these 
findings and compared them with that of an in vitro human model that our discoveries 
can begin to answer complex questions concerning human health. This is perhaps the 
most exciting part of studying the homology of the animal kingdom.   
 
5.2: Vascular Regeneration Throughout the Life Cycle 
The animal vascular system is a complex network that, much like other systems in 
the body, must remain constantly responsive to environmental cues and perturbations. 
Larger vessels, such as that of the aorta and superior vena cava, are comprised of 
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endothelial cells and mural cells (smooth muscle cells) that sustain necessary structural 
integrity. In contrast, smaller vessels, such as those contained in dense capillary networks 
within tissues, are solely comprised of endothelial cells. During development, arterial 
growth precedes capillary angiogenesis and reigns as the principle method of 
vascularization; however, the adult life cycle is almost entirely characterized by small 
instances of capillary angiogenesis that give rise to new vessels upon tissue damage or 
regeneration (Luttun, Carmeliet, & Carmeliet, 2003; Carmeliet, 2003).   
Normal vascular alterations that occur during the adult life cycle tend to be placed 
in one of three categories—that of immune-driven angiogenesis (in response to 
inflammation), coagulation (wound healing/clotting), and vessel regression. 
Hematopoietic and angiogenic factors that are featured in these three mechanisms are 
produced in the bone marrow during this stage of the life cycle (the job of hematopoietic 
stem cells) and are mainly controlled by the master angiogenic regulator “vascular 
endothelial growth factor” (VEGF) (Luttun, Carmeliet, & Carmeliet, 2003; Carmeliet, 
2003). Other important molecular players in adult angiogenesis include placental growth 
factor (P1GF, a homolog of VEGF), angiopoietin 1 (ANG-1), angiopoietin 2 (ANG-2), 
and various signaling cytokines that respond to a wide variety of environmental cues 
(Carmeliet, 2003). In contrast to the ETF family of transcription factors, there has been 
substantial research concerning how these homologous factors play a role in both normal 
animal development and adult disease etiology.  
 Adult endothelial cells do not exhibit identical gene expression patterns across 
tissue systems. Expression gradients of VEGF and ANG-1 between vessels contribute to 
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these tissue and site-specific expression profiles (Carmeliet, 2003). A great example of 
this variability is found in a comparison of low-permeability and high-permeability 
tumors in cancer—while low-permeability tumors generally overexpress ANG-1 and 
dramatically under express VEGF, high-permeability tumors lack ANG-1 expression 
almost altogether. This pattern of differential expression among subtypes of many 
diseases implicates the need for researchers to identify organ-specific molecules and site-
specific treatment methodologies (Jain & Munn, 2000). 
 
5.3: Tumorigenesis—Hijacking the Vascular Machinery 
The vascular system provides one of the most important functions for the support 
of multicellular organization—that of consistent nutrient and oxygen access. Due to the 
diffusion limit of oxygen, all mammalian cells must be situated within 100 to 200 
microns of blood vessels, a very small window of access. Actively dividing groups of 
cells within the body are even more reliant on nearby vessels, as a constant influx of key 
cellular building blocks and nutrients is absolutely required for successful proliferation. 
To support growth, the body must employ angiogenesis in novel tissue areas that do not 
have a robust, pre-existing vascular network (Carmeliet & Jain, 2000).  But what about 
those instances in which angiogenesis and nutrient acquisition go haywire? 
 The first documented model of tumor angiogenesis in cancers was proposed in 
1971, and since then has become a topic of immense research within the biomedical 
community. Most research to date that has been conducted on the molecular mechanisms 
of tumor angiogenesis has utilized xenograft and tumor implantation models. While these 
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models certainly have helped us elucidate why pathological angiogenesis is so important 
to tumor growth and stability, these models are inevitably different than naturally 
occurring, in vivo tumors found in patients. A spatiotemporal model of tumor 
angiogenesis still remains to be explored (Liao & Johnson, 2007).  
While we may not yet have a complete picture of the relationship between tumor 
pathology and angiogenesis, considerable research since 1971 has found that tumor 
vascularization is heavily reliant on microenvironmental characteristics. Before a tumor 
is capable of growing in diameter above a 1-2-millimeter threshold, it must acquire more 
blood vessels than can be readily supplied by its surrounding normal tissue (Carmeliet, 
2005). Termed the “angiogenic switch,” tumors are capable of moving from a non-
angiogenic to angiogenic state through the activation of hypoxia-inducible factors (HIFs), 
a group of transcription factors that respond to low oxygen conditions in a tissue’s 
microenvironment (Liao & Johnson, 2007). Hypoxia is the condition in which cells 
extend out of the geographic reach of the oxygen diffusion rate; in tumorous cancers, 
aberrant cells are capable of hijacking the body’s natural angiogenic machinery and 
bypassing many cellular checkpoints that inhibit uninterrupted cell growth (Carmeliet & 
Jain, 2000). Many well-known and biomedically relevant HIFs are induced by VEGF and 
can experience upwards of a 30-fold induction within the span of only a few minutes, 
indicating that timing is of critical importance to this signaling cascade. HIFs are 
notoriously implicated in cancer, especially in the instance of tumor growth; as cancerous 
masses grow in diameter and density, their need for readily-available nutrients and 
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oxygen becomes larger and forces the hyper-activation of capillary angiogenesis 
(Carmeliet, 2003).  
 In an actively angiogenic tumor, vessels develop via intussusception (sprouting 
from pre-existing vessels) and are influenced by the presence of circulating endothelial 
progenitor cells. Some tumors are capable of growing around existing vessels, creating 
what is called a “perivascular cuff.” Unlike normal tissue, tumorous vessels tend to 
appear sporadic and disorganized, often feature uneven diameters, are highly dilated, and 
have far too many branches to be stable over time. Perhaps unsurprisingly, these vessels 
often lack a functional basement membrane, a type of extracellular matrix (ECM), and 
are remarkably leaky, which likely relates to problems with the spatiotemporal expression 
of VEGF and the angiopoietins (Figure 5.1) (Carmeliet & Jain, 2000; Tonini, Rossi, & 
Claudio, 2003). de novo vasculature is capable of forming both in and around the tumor, 
yet in both instances will be undeniably abnormal; because these vessels are poorly 
constructed, the tumor continues to produce pro-angiogenic factors for repair, leading to a 
perpetual cycle of shabby vessel production. Due to its intriguing expression profile in 
numerous tumor subtypes, VEGF remains an intriguing (albeit difficult) target for 
anticancer therapies (Carmeliet, 2005).  
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Figure 5.1. Schematic of blood vessel overgrowth in response to VEGF secretion by an 
actively growing tumor. An increase in blood vessel density leads to increased oxygen 
and nutrient access, which supports cancer proliferation and possible metastasis. Adapted 
from “Angiogenesis Inhibitors,” 2018.  
 
 Originally, it was thought that tumors were capable of producing a unique 
“angiogenic molecule” that could induce other pro-angiogenic factors to become heavily 
expressed. We now know, however, that many of the issues in vessel number and quality 
in tumors are linked to the relative balance in expression of pro and anti-angiogenic 
factors, suggesting that tumors may grow to remarkable sizes simply because the 
expression of anti-angiogenic factors cannot keep up with that of pro-angiogenic factors. 
In most tumors, VEGF and the angiopoietins have poorly coordinated temporal 
expression patterns. VEGF seems to respond based on gene dosage, implying that 
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duplication of this growth factor may also activate tumorigenesis via neovascularization. 
Interestingly, many of the leaky features associated with tumor vessels are linked to the 
lack of functional perivascular cells surrounding these vessels; without a homogenous 
layer of endothelial cells, which are functional based on proper VEGF expression, vessels 
become amenable to plasma leakage and significant ECM damage. It has even been 
postulated that these endothelial cells are not endothelial at all—instead, they are simply 
tumorous cancer cells that mimic the expression profiles of endothelial cells via a 
mechanism of “vasculogenic mimicry.” It is important to note that dormant tumors 
(tumors that are not actively growing in size) tend to express pro-angiogenic and anti-
angiogenic factors at relatively equivalent levels, further implicating this precarious 
balance as a potential therapeutic target (Carmeliet, 2005; Carmeliet & Jain, 2000).  
 Besides an imbalance between the expression of pro-angiogenic and anti-
angiogenic factors in tumor cells, hematopoietic cells and nitric oxide synthases have 
been implicated in the vascularization of cancerous tissues. Hematopoietic cells are 
canonically involved in the downregulation of angiogenesis following the completion of 
neovascularization; in cancerous tissues, however, it is possible that hematopoietic cells 
found in new vessels do not release enough (or the “right”) factors to inhibit further 
angiogenesis (Carmeliet & Jain, 2000). In addition, nitric oxide synthases, a class of 
enzymes that are activated by HIFs and help modulate vascular toning through the 
production of nitric oxide, are capable of acting as endothelial cell survival factors. These 
factors support apoptosis inhibition and excessive proliferation. While NO synthases 
certainly play a role in normal angiogenesis, cancerous tissues appear to upregulate and 
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modulate their expression such that nitric oxide is produced in remarkable excess (Liao & 
Johnson, 2007). The relatively new discovery of these factors in contributing to 
pathological angiogenesis in cancerous tumors opens up the possibility for even more 
therapeutic targets.  
 VEGF remains as a promising target for molecular cancer therapeutics in patients 
with actively growing tumors; like other pathological phenotypes associated with adult 
angiogenesis and neovascularization, however, VEGF plays many roles outside of 
vascular regeneration and remains a convoluted target. For example, besides its role in 
activating macrophage recruitment and supporting vessel development, VEGF also has 
been shown to help “protect” against stroke through mediating neurogenesis and vascular 
renewal throughout the adult brain. VEGF even plays a role in bone health throughout the 
adult life cycle, with its conditional deletion relating to severe age-related bone loss. 
Unsurprisingly, VEGF expression is also necessary for normal alveolar repair in the 
lungs (Liao & Johnson, 2007). Until we have devised a therapeutic technology in which 
conditional downregulation of a target transcript may be spatiotemporally controlled in 
an in vivo model, VEGF and other “high-impact,” master regulatory transcription factors 
remain dubious as therapeutic targets.  
 
5.4: Inflammation and Wound Healing—Responding to a Nick 
Inflammation, wound healing, and vessel regression are all reactions of the body 
to diverse environmental cues and stressors. Inflammation, a localized process in which 
the immune system becomes activated in response to injury or infection, initiates 
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angiogenic sprouting through the recruitment of mast cells (a type of white blood cell) 
and the release of vasoactive/angiogenic factors. An inflamed section of tissue must 
support capillary growth simply because increased quantities of oxygen and nutrients are 
required for cellular growth and repair. At the molecular level, angiogenic factors 
function to amplify inflammatory signals by recruiting increasing numbers of 
lymphocytes to the site of injury. Many of these mechanisms are mimicked in 
coagulation (wound healing); upon injury, fibrin clots are formed through platelet 
aggregation before angiogenesis-driven capillary repair may begin. Like white blood 
cells, platelets store and release large quantities of angiogenic factors that contribute to 
the regulation of microvessel density, a process that often becomes pathogenic in cancer 
(Carmeliet, 2003; Luttun, Carmeliet, & Carmeliet, 2003).  
Traditionally, it was thought that angiogenesis was the only possible mechanism 
in which new vascularization could arise in the adult organism; however, it has been 
demonstrated that EPCs (endothelial progenitor cells) circulate in the peripheral blood 
stream postnatally and are capable of incorporating into sites of active neovascularization 
through vasculogenic mechanisms (Kalka et al., 2003). Both larger arterial/venous 
growth and capillary angiogenesis seem to play distinct roles in adult vascular 
homeostasis, and as such have been targeted as potential therapeutic topics for numerous 
biomedical diseases. Some of the most well-known disorders associated with excessive 
vessel growth include cancer, psoriasis, arthritis, obesity, and asthma, while diseases 
implicated in insufficient vascular growth and abnormal vessel regression include 
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ischemia, neurodegeneration, hypertension, pre-eclampsia, osteoporosis, and various 
respiratory disorders (Carmeliet, 2003).  
 Chronic wounds, a class of injuries in which healing does not occur properly and 
during a predictable amount of time, are common in the general population (Tonnesen, 
Feng, & Clark, 2000). As a remarkably heterogeneous condition, the impaired ability to 
heal chronic wounds is often associated with other diagnosed conditions, such as that of 
diabetes and autoimmune dysfunctions. People who suffer from the inability to heal such 
wounds often produce macrophages that are incapable of producing sufficient levels of 
cytokines, a class of inflammatory molecules that trigger countless signal cascades for 
cellular damage repair and infection control. This lack of cytokines also indirectly 
contributes to decreased rates of angiogenesis at the site of injury; without angiogenesis 
and the formation of new blood vessels, a damaged tissue is unable to acquire the 
necessary nutrients and oxygen for successful, timely healing (Wu, Chen, Scott, & 
Tredget, 2007).  
 Upon cytokine release and inflammatory induction at a site of injury, normal adult 
wound healing factors trigger two primary phases of blood vessel integration. The first, 
which lasts roughly 24 hours in adults, is characterized by increased rates of dilatation 
(dilation of blood vessels), vessel hyperpermeability, endothelium activation, and 
diapedesis (a recruitment of macrophages to the site of injury). The second phase, which 
conversely lasts until the wound is fully healed, features dramatic vascular remodeling 
and functional changes needed to support new tissue growth. Either of these phases may 
be disrupted and lead to a wide array of diseased phenotypes; however, many problems 
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can be traced back to macrophage ineptitude and abnormally low cytokine activity 
(Majno, 1998).  
 For external wounds such as cuts or gashes, macrophage recruitment is generally 
the first step of a localized inflammatory response. Macrophages at the site of injury are 
responsible for producing cytokines that stimulate the onset of fibroplasia (new tissue 
formation) and angiogenesis. Fibroblasts, a group of cells that produce collagen and other 
fibers necessary for tissue regeneration, are responsible for producing new materials for 
the underlying extracellular matrix in the wound, while new blood vessels supply the 
oxygen and nutrients required for the fibroblasts to initiate repair. Angiogenic factors that 
are released by macrophages during wound healing include fibroblast growth factors 
(FGFs), VEGF, TGF-β, ANG-1, and ANG-2. Interestingly, the initial production of 
VEGF upon wound healing is initiated by the injured epidermal cells at the site of 
perturbation (not site-recruited macrophages). These epidermal cells begin to produce 
VEGF upon induction by HIFs, which subsequently activates all resulting signal cascades 
(Figure 5.2) (Tonneson, Feng, & Clark, 2000).  
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Figure 5.2. Schematic of the molecular signaling cascades associated with traditional 
wound healing. (A) VEGF, among other angiogenic factors, is secreted by neutrophils 
both in and underneath the site of injury, which promotes blood vessel growth via 
activation of angiogenesis. (B) New blood vessels appear directly beneath the site of 
perturbation as soon as five days after injury. Adapted from Singer & Clark, 1999.  
 
FGF-1 and FGF-2 are released by resident macrophages immediately following 
tissue disruption. This increase in FGF expression activates the upregulation of VEGF by 
macrophages within the newly hypoxic microenvironment of the injury and recruits 
proteolytic enzymes. Among other tasks, the principle role of proteolytic enzymes in a 
wound is to degrade the underlying, damaged ECM. The deposition of collagen, 
fibronectin, and elastin by fibroblasts in this region also recruits neighboring blood 
monocytes and supports their differentiation into macrophages. This rapid increase in 
macrophage recruitment amplifies the angiogenic signals of ANG-1 and ANG-2 and 
induces capillary sprouts to form and migrate in response to pre-established FGF/VEGF 
gradients. This highly regulated spatiotemporal mechanism allows for new blood vessels 
to establish a provisional matrix, a step necessary for collagen-rich scar tissue to 
repopulate the tissue (Figure 5.2) (Tonneson, Feng, & Clark, 2000).  
[A] [B] 
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The complex interactions between new cells, cytokines, and the underlying 
provisional matrix (ECM) in a tissue during wound healing is termed “dynamic 
reciprocity.” Surprisingly, it takes upwards of four days for post-injury capillary sprouts 
to begin migration out of “mother” vessels surrounding the site of injury. Collagen 
deposition on top of the provision matrix is inversely associated with capillary density 
during this time and is also slow to accumulate (Tonnesen, Feng, & Clark, 2000). Even 
though many of the vessel regeneration mechanisms in the wound healing cascade are 
reliant on angiogenesis, some endothelial cells in sprouting vessels are derived from 
circulating stem cells in the blood, suggesting that vasculogenic mechanisms may not be 
entirely silenced during the adult life cycle (Majno, 1998). Mesenchymal stem cells in the 
vicinity of active wounds also allow for increased capillary density and increased rates of 
angiogenesis in wounded tissue, but function through a paracrine (hormonal) mechanism. 
Like macrophages, fibroblasts, and wounded epithelial cells, mesenchymal stem cells are 
capable of secreting high levels of VEGF-𝛼 and ANG-1, indicating that the adult body 
has numerous mechanisms in which angiogenesis may become activated upon external 
injury (Wu, Chen, Scott, & Tredget, 2007).  
 
5.5: Inflammation in the Asthmatic Airway 
 At first glance, there is no reason to suspect that vascular remodeling could 
possibly play a role in the symptomology of a common pulmonary disorder like asthma; 
however, along with mucous metaplasia, two common features of the asthma phenotype 
are smooth muscle hypercontraction and increased airway thickness, both of which are in 
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part the result of abnormal tissue vascularization. The acquisition of abnormally large 
networks of vessels in asthmatic airways, regardless of phenotypic severity, allows for 
increased blood flow and microvascular permeability; as capillaries become 
hyperpermeable and “leaky,” plasma accumulates on the underlying ECM of the lungs 
and contributes to the smooth muscle contractions characteristic of an asthma attack 
(Ribatti et al., 2009). Remodeling of the airway vasculature in asthmatic patients also 
contributes to the overall increased airway wall thickness, luminal narrowing, and 
hyperresponsiveness to inhaled environmental stimuli characteristic of the clinical asthma 
subtypes (Feltis et al., 2006). 
 At the molecular level, the abnormal release of fibrogenic growth factors like 
TGF-β, tumor necrosis factor-α, and basic FGF all contribute to the high rates of 
angiogenesis found in the lungs (Feltis et al., 2006). Unlike in other tissue systems, 
VEGF plays many distinct roles in the lungs, including that of regulating capillary 
hyperpermeability in vivo. VEGF is produced and secreted by alveolar endothelial cells, 
bronchial endothelial cells, smooth muscle cells, fibroblasts, and macrophages, and it 
affects pulmonary immune responses to environmental stimuli (such as pollen or 
pathogens) by amplifying the inflammatory hyperactivity characteristic of the TH-2 
asthma subtype. Cytokines also secreted by these cells, such as IL-4, IL-5, and IL-13, are 
also secreted by smooth muscle cells that line the airways and enhance VEGF production 
(Figure 5.3). Due to its remarkable expression in almost every cell type in the adult 
airway and elsewhere in the body, VEGF has proven to be a difficult target for 
biomedical inquiry (Ribatti et al., 2009). 
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Figure 5.3. Schematic of the general vasculogenic and angiogenic mechanisms promoted 
by the airway epithelium of the lungs. Angiogenic factors like the angiopoietins (ANG) 
and the vascular endothelial growth factors (VEGF) play a crucial role in the initiation 
and propagation of neovascularization in the normal epithelium. Adapted from Carmeliet, 
2000.  
  
Another family of angiogenic factors implicated in the general asthma phenotype 
is that of the angiopoietins. Coupled with high levels of VEGF, ANG-2 supports a rapid 
increase in the diameter of lung capillaries and induces angiogenic endothelial cells to 
proliferate and migrate (Ribatti et al., 2009). ANG-1, an angiopoietin that functions 
alongside VEGF expression, is responsible for maintaining quiescence and stability of the 
mature adult vasculature throughout the lungs. Disruption of ANG-1 expression has been 
found to lead to aberrant VEGF reactivation and subsequent hyperactivity of angiogenic 
sprouting, suggesting that ANG-1 may act as an indirect regulatory molecule for 
dampening the extreme effects of high VEGF levels in the lungs (Feltis et al., 2006). 
Vessel sustainment, a process that is aberrantly regulated in asthmatics, is also controlled 
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by relative concentrations of VEGF and ANG-1, as asthmatic airways have increased 
vessel numbers overall, larger numbers of small vessels (indicating high angiogenic 
activity), and abnormally “leaky” vessels that promote extreme tissue swelling. 
Interestingly, vascular sprouts are not unique to asthmatics in the airway; rather, it is the 
incorrect timing and intensity of angiogenic signaling in patient airways that contribute to 
the phenotype of smooth muscle hypercontraction (Feltis et al., 2006).  
 A major area of biomedical research for the development of asthma therapeutics 
has focused on how cytokine release and inflammatory stimulation relate to the 
accumulation of angiogenic factors in the asthmatic airway (Ribatti et al., 2009). 
Pulmonary eosinophil infiltration (macrophage recruitment) has been successfully 
reduced in a murine model through the injection of anti-VEGF receptor antibodies, more 
commonly called by its trade name, Avastin (Lee, Kwak, & Song, 2002). Given the 
molecular homology of adult angiogenesis throughout the body, it is unsurprising that 
Avastin is also a potent chemotherapeutic. While direct inhibition of VEGF activity 
would in theory allow for an overall dampening of angiogenic hyperactivity in the lungs, 
VEGF is important for too many other normal functions in the airway (as well as 
throughout other organ systems in the adult body) and would likely lead to dramatic side 
effects in vivo. It is important to note that besides dampening the effects of smooth 
muscle hypercontraction, inhaled corticosteroids also suppress VEGF transcription in 
vitro, suggesting that some of their efficacy in asthmatic patients may be related to the 
added effects of VEGF downregulation and smooth muscle relaxation (Ribatti et al., 
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2009). Overall, much remains to be discovered concerning the potential targeting of 
angiogenic factors in the treatment of asthma.  
 
5.6: Menses & Endometriosis 
 Perhaps the most obvious example of the role of angiogenesis in the adult life 
cycle can be found in the female menstrual cycle. Physiological angiogenesis within the 
female reproductive system occurs in the ovaries, endometrium, and placenta during 
pregnancy. VEGF is expressed at varying levels throughout the estrus cycle, and 
placental growth factor (P1GF) is so named because of its specific role in supporting 
angiogenesis between mother and child during gestation. Like mesenchymal stem cells in 
wound healing, VEGF mRNA expression in the endometrium (mucous membrane lining 
the uterus) is activated through hormonal regulation cascades involving estradiol and 
progesterone. Much like in the human airway, cytokines are also implicated in the 
upregulation of angiogenic factors; uterine natural killer (NK) T cells, small granular 
cells that reside in the proliferative endometrium, produce high levels of cytokines during 
the secretory phase of the estrus cycle that consequently activate angiogenic activity in 
the uterus. While the normal endometrium suppresses VEGF-C, ANG-1, and ANG-2 
expression, NK T cells express multiple pro-angiogenic factors that may be principally 
implicated in the cyclical endometrial regeneration of menses. Furthermore, VEGF 
promotes NK T cell adhesion to underlying endothelial cells in the female reproductive 
tract, suggesting that NK cells have a unique role in supporting endometrial angiogenesis 
(Li et al., 2001). 
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Figure 5.4. Schematic of molecular signaling cascades associated with (a) the 
proliferative phase and (b) the end of the secretory phase of menstruation. VEGF-α and 
ANG-1/ANG-2, like other parts of the body reliant on neovascularization, play a major 
role in response to cyclical hormonal cues, such as that of estradiol and progesterone. 
Adapted from Smith, 2001.  
  
Endometriosis, a reproductive disorder characterized by excessive endothelial 
growth outside of the uterus, is associated with dysfunctional inflammatory reactions 
within the endothelium during menses. Characterized by chronic cystic lesions 
throughout the reproductive tract, endometriosis occurs when exfoliated endometrium 
becomes aberrantly deposited in the peritoneal cavity following the completion of 
menstruation. This ectopic deposition of tissue invokes a local inflammatory response in 
which macrophages release excessively high concentrations of cytokines and 
subsequently invoke angiogenic neovascularization. VEGF is found in high 
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concentrations in the peritoneal fluid of patients with endometriosis, even though cyclic 
variations occur based on menstruation phase (higher in proliferative phase compared to 
secretory phase) (McLarne, Prentice, Charnock-Jones, & Smith, 1996). Much like other 
adult physiological mechanisms that rely on neovascularization, it seems as if 
angiogenesis is not the only process implicated in endometriosis—post-natal 
vasculogenesis and circulating endothelial progenitor cells have been implicated in 
endometriosis pathogenesis and high expression of numerous angiogenic factors in the 
uterus (Laschke, Giebels, & Menger, 2011).  
 
5.7: Summary 
 What could cancer, wound healing, airway hypervascularization, and 
endometriosis possibly have to do with the homology of development? While 
pathological adult conditions such as these may not seem to relate to the homologous 
pathways that have defined the evolution of the animal kingdom, it appears as if many of 
the master regulators that play a major role in development are often reactivated and 
misused in adult diseases. Transcription factors like VEGF and the angiopoietins are not 
meant to be silenced during adulthood; however, because of their diverse roles during 
development and beyond, their aberrant expression often leads to large-scale phenotypic 
effects that relate to clinically relevant diseased phenotypes. It is foolish to think that 
developmental proteins become irrelevant following birth; because of the masterful 
tinkering of evolution, mammalian molecular circuitry remains both beautifully intricate 
and devastatingly connected.  
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Chapter 6 
CONCLUSION 
 
 ETS TFs, VEGF, and the angiopoietins are certainly not the only examples of 
how homologous molecules impact development and disease etiology. Homology colors 
the very core of what it means to understand multicellularity—without it, the transition 
from “bench to bedside,” i.e. the connectivity between basic and translational research, 
would be inaccessible and unattainable. The study of evolution need not be solely 
practical for the sake of organismic biology and ecological conservation; a doctor’s office 
seems to be just as amenable to evolutionary discovery as a paleontological dig.  
  
 If we are to continue bridging the gap between human evolution and medicine 
through the scope of homology, then what is the complete narrative with which we must 
operate? And how do we decide which lens is the right fit for “viewing” homology? 
Countless years of utilizing model organism systems has taught us that homology is 
simply the stamp left behind from “our lowly origins.” At the time of the Cambrian 
explosion, the genomic framework for the animal kingdom was established in a simple 
bilateral organism with enormous evolutionary potential. Amid constraints from an ever-
changing environment, the animal genome diversified through mutational events coupled 
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with the beautiful simplicity of natural selection. Gene duplications and “trial-and-error” 
alterations of CREs likely allowed for incremental changes in gene regulatory networks 
that continued to support rapid speciation and diversification. This model, which Darwin 
aptly titled “Descent with Modification,” stipulates that the fundamental building blocks 
of the animal kingdom have been contained in an “ancient genetic toolkit” that is found 
within each extant species today. The beauty of this model of evolution is that it largely 
explains why model organism studies remain so effective. We still know relatively little 
about the regulatory capacity of the human genome; however, it is through the holistic 
lens of developmental homology that these patterns of evolutionary novelty are most 
likely to be elucidated. 
 At first glance, my research project at Cincinnati Children’s Hospital would seem 
to be unrelated to evo-devo and homology. What could the identification of a new 
progenitor population implicated in zebrafish vasculogenesis and angiogenesis have to do 
with the larger patterns of animal evolution? If homology tells us anything, it is that novel 
discoveries in one organism are often found in others throughout the phylogenetic tree. 
When I presented my research at a poster symposium at the conclusion of the summer, I 
met a mouse biologist who expressed interest in determining if PAC cells are found in a 
murine model of circulatory development—little did she know that her interest in 
applying my findings to research in her own lab was grounded in the fundamental 
principle of animal homology!  
  My project continues to function as a preliminary investigation into how PAC 
cells shape zebrafish vascular development; however, should our laboratory successfully 
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demonstrate that these cells are an evolutionarily conserved population, our findings 
would have the potential to impact future studies on biomedical vascular regeneration. 
Given what we know about the pervasive nature of molecular homology, it would be 
unsurprising to find that PAC cells have human analogs. The simple knowledge that so 
many deeply homologous transcription factors shape vascular development throughout 
the animal kingdom indicates that such discoveries are both entirely feasible and 
significantly important.  
When I began formulating a trajectory for this thesis, I had very little foresight 
into the awe-inspiring discoveries that I would make about animal homology. I was well 
aware that homology is an overarching facet of the evolution of life itself; however, I was 
completely unaware of how much biomedical inquiry has been reliant on the simple 
homology of eukaryotic protein networks. I was dumbfounded to learn that the vastly 
disparate topics of cancer, wound healing, asthma, and endometriosis are all connected 
via a few homologous transcription factors—how humbling it is to witness the beautiful 
design of creation through such simple molecules. The writing of this thesis has been a 
profoundly religious experience for me. Who would have guessed that a narrative of 
homology would end up being my most poetic prayer.  
 
Moment of peace like brief arctic bloom 
Red-gold ripple of the sun going down 
Line of black hills makes my bed 
Sky full of love pulled over my head 
In this world of wonders 
 
“World of Wonders” 
--Bruce Cockburn 
